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Abstract 
  Hyperglycaemia-induced oxidative stress plays an important role in cardiomyocyte 
cell death leading to cardiac dysfunction. Autophagy is an intracellular bulk degradation 
process and can be induced by stressors such as nutrient depletion and acute ischemia, to 
promote cell survival. Oxidative stress is an important regulator of autophagy in various 
pathophysiological conditions such as ischemia/reperfusion injury and hypoxia. The role 
of autophagy in the oxidative stress tolerance of cardiac cells exposed to simultaneous 
hyperglycemia and hypoxia has not been studied. The aim of the present study is to 
determine the role of autophagy in cardiac cells in response to combined hyperglycemia 
and hypoxia. H9c2 rat cardiac cell lines were grown in DMEM supplemented with 
standard (5.6 mM), moderately high (25 mM) and high (33 mM) glucose concentrations. 
The cells were then exposed to hypoxia condition (1% oxygen, O2) for 24h and 48h using 
the hypoxia chamber. Cell viability and oxidative stress was measured by the 2,5-
diphenyl-2H-tetrazolium bromide (MTT) and 2'7'-dichlorofluorescein (DCF) assays 
respectively. Apoptosis and autophagy was assessed via Caspatag 3/7 In Situ assay and 
western blotting. Results obtained demonstrated that high glucose andhypoxia additively 
reduced H9c2 cell viability. Simultaneous high glucose and hypoxia-induced oxidative 
stress suppresses autophagy and promotes cell death by apoptosis. A biphasic induction 
of ROS production, caspase 3/7 activity and PAMPK protein expression, in simultaneous 
high glucose and hypoxia conditions, calls for further research.  
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Lay Summary 
 
  Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia 
and vascular complications that lead to cardiovascular dysfunction such as heart attack. 
Increased oxidative stress has been proposed as a molecular mechanism for vascular 
complications in diabetes mellitus. Autophagy, an intracellular bulk degradation process, 
occurs at basal levels but can be further induced by stressors such as hypoxia or high 
glucose to promote cell survival or programmed cell death (PCD), respectively. Our 
research goal aims to investigate and understand the cumulative effects of hyperglycemia 
and hypoxia on cardiac oxidative stress, by studying autophagic and PCD markers, in an 
in vitro model. Our results suggest that simultaneous high glucose and hypoxia 
treatments induce reactive oxygen species production, diminish autophagy and promote 
PCD. Manipulation of these processes may allow for increased cardiac cell survival and 
contribute to developing better therapeutic approaches for diabetic individuals. The 
diversity of life is vast but with each study it might just become a little less complicated.  
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Introduction 
 
1.1 Diabetes 
  Diabetes mellitus is a metabolic disorder of multiple etiology characterized by 
chronic hyperglycemia and a set of micro-vascular and macro-vascular complications that 
substantially increase morbidity and mortality. Diabetes mellitus type 1 involves 
defective insulin secretion and systemic hyperglycemia (Matschinsky et al. 2002). 
Diabetes mellitus type 2 is characterized by two main pathogenic disorders: impaired 
pancreatic β-cell insulin secretion and peripheral insulin resistance in muscle and liver 
tissue (Alberti et al. 1998, DeFronzo et al. 1992). Diabetes is characterized by endothelial 
dysfunction (Caballero et al. 1999), which leads to vascular reactivity related to 
cardiovascular dysfunction such as myocardial infarction and arrhythmia (Halcox et al. 
2002).  
  Mortality from cardiac diseases is approximately two- to four-fold higher in 
patients with diabetes than in those who have the same magnitude of vascular diseases 
without diabetes (Johnstone 2000). Diabetes-induced cell death has been observed in 
multiple organs in vivo (Cai et al. 2000; Alici et al. 2000; Srinivasan et al. 2000). In 
laboratory settings, young adult animals administered with streptozotocin (STZ), a widely 
used diabetogenic agent, produce metabolic characteristics that resemble the features of 
type 1 diabetes mellitus (Islam et al. 2009). The apoptotic rate has been shown to increase 
in the heart of diabetic patients (Frustaci et al. 2000) and STZ-induced diabetic animals 
(Fiordaliso et al. 2000). Several studies have shown that hyperglycemia, as an 
independent risk factor, directly causes cardiac damage leading to diabetic 
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cardiomyopathy (Singh et al. 2000). STZ-induced diabetic animal heart models display 
cardiomyocyte apoptosis, compensatory myocardial hypertrophy, and reparative 
interstitial and perivascular fibrosis at the late phase of diabetic cardiomyopathy 
(Chatham et al. 1996). Because myocytes rarely proliferate in adult cardiac muscles, the 
loss of cardiac muscle cells, by apoptosis, would eventually lead to compromised cardiac 
function such as decreased myocardial performance (due to the loss of contractile tissue) 
(Swynghedauw 1999) and ventricular dilation (Frustaci et al. 2000). These late-phase 
changes are believed to result from early responses of myocardium to suddenly increased 
glucose levels (Johnstone 2000; Chatham et al. 1996, Depre et al. 2000). Early responses 
of myocardial cells to hyperglycemia include metabolic abnormalities and abnormal 
expression of genes such as decreased expression of glucose transporter (GLUT)-1, 
GLUT4, sarcoplasmic calcium cation adenosine triphosphatase and carnitine 
palmitoyltransferase I (Depre et al. 2000). These early responses consequently result in 
cardiac cell death (Cai and Kang 2001). Inhibition of increased glucose levels, by insulin 
supplementation, almost completely prevents myocardial morphological abnormalities 
and partially inhibits myocardial cell death. This indicates that severe hyperglycemia that 
needs to reach a threshold may be necessary for the development of early morphological 
abnormalities, whereas apoptotic cell death may be a dose-dependent response to 
hyperglycemia (Cai et al. 2002).  
 
1.2 Oxidative stress and its links to cardiovascular disease 
          Diabetes, coronary artery disease, hypertension, smoking and alcoholism are 
claimed to account for deviations from redox homeostasis (Diaz-Velez et al. 1996). 
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Redox homeostasis/balance describes repairing unstable, damaging, reduced, reactive 
oxygen species (ROS) by a process of reduction (gain of electrons) and oxidation (loss of 
electrons). Ideally there should be a balance between ROS production and the activities 
of non-enzymatic and enzymatic antioxidant systems, which strive to reduce ROS 
concentrations (Gutteridge et al. 2000). ROS are very chemically reactive, they can exist 
as either as a free radical (species with at least one unpaired electron) such as superoxide 
(O2•¯) and hydroxyl radicals (OH•) or non-radical species such as hydrogen peroxide 
(H2O2). Redox stress however; is when there is an imbalance between ROS and 
antioxidant capacity, this is caused by an overproduction of ROS either via reduction or 
oxidation or reduced antioxidant reserves. Oxidative stress involves an imbalance due to 
an excess of ROS produced through oxidation (Hayden et al. 2002).  The accumulation of 
ROS can implement cell death, for example, H2O2 has been observed to encourage adult 
cardiomyocyte death (Kwon et al. 2003) by apoptosis or necrosis. But lower levels of 
ROS are cytoprotective (Pandya et al. 2002) and may promote cell proliferation, thus the 
balance between cell growth and cell death can be altered by the amount of oxidative 
stress within a cell (Finkel et al. 1998). 
Increased oxidative stress has been proposed as a molecular mechanism for 
vascular complications in diabetes mellitus (Creager 2003; Kang et al. 2002). Patients 
with type 2 diabetes show increased levels of circulating markers of free radical-induced 
damage and reduced antioxidant defenses (Farahmand et al. 2003; Davi et al. 2005). 
Factors such as hyperglycemia and glucose autoxidation have been reported to contribute 
to increased ROS generation in diabetes (Jay et al. 2006). Increased mitochondrial H2O2 
production and reduced glutathione  levels have been observed to occur in diabetic hearts 
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(Nishio et al. 2004). Endothelial cells exposed to high glucose levels, relevant to clinical 
diabetes (25 mM), were found to produce increased O2•¯ levels. Hyperglycemia-induced 
generation of mitochondrial O2•¯ may be the initial trigger of oxidative stress in diabetes 
(Aronson 2008). Increased O2•¯ production from non-mitochondrial sources include; 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Li et al. 2006). The 
activity of this enzyme is found to be elevated in vascular tissue obtained from diabetic 
patients (Guzik et al. 2002).  
Interestingly, inactivation of nitric oxide (NO), a signaling molecule, by ROS 
plays an important role in reducing NO bioavailability and the development of 
endothelial dysfunction (Creager 2003; Kang et al. 2002). Increased ROS production also 
contributes to the development of insulin resistance, while reduced ROS levels result in 
improved insulin sensitivity (Houstis 2006). Markers of oxidative stress are increased 
with diabetes and insulin resistance (Urakawa 2003).  
Pancreatic β-cells are sensitive to oxidative stress because of low antioxidant 
enzyme expression such as superoxide dismutase (SOD), catalase (CAT) and glutathione 
peroxidase (Tiedge et al. 1997). Increased β-cell death, in diabetes (Mandrup-Poulsen 
2001), has been shown to be due to increased oxidative stress and impaired insulin 
secretion, both of which can be attenuated by antioxidant (N-acetylcysteine) treatment 
(Robertson et al. 2003). It has also been predicted that the maladaptive decline in 
antioxidant enzyme expression or activity may contribute to the progression to heart 
failure (Sam et al. 2005). 
 
1.2.1 Diabetic Inflammatory response-induced oxidative stress 
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An inflammatory response in the diabetic condition may induce oxidative stress 
and also contribute to the development of diabetic cardiomyopathy (Khansari et al. 2009). 
In hyperglycemia, both inflammatory cytokine production by monocytes and binding of 
inflammatory cells to the endothelium is increased (Rolo and Palmeira 2006; Basta et al. 
2004). Type 1 and 2 diabetes has been characterized by intra-myocardial inflammation, 
increased tumor necrosis factor (TNF) α expression, oxidative stress and myocardial 
fibrosis. TNFα is known to reduce myocyte contractility and increase tissue fibrosis, 
contributing to cardiac failure. Anti-TNFα antibody treatment has been shown to 
significantly ameliorate intramyocardial inflammation and myocardial fibrosis associated 
with diabetic cardiomyopathy (Westermann et al. 2007).  
 
1.3 Apoptosis 
  Programmed cell death (PCD) is essential for elimination of damaged and diseased 
cells, malignant cells and tissue remodeling during development. Cellular components 
undergo a controlled enzymatic digestion, allowing surrounding tissue to escape 
excessive damage and consequent inflammation due to release of toxic substances from 
cells that die in an uncontrolled manner, such as through necrosis. Necrotic cell death 
involves cell swelling, plasma membrane rupture and occurs when the degree of damage 
is too high and/or PCD is somehow disturbed. Irreversibly damaged, diseased and 
nonessential cells can initiate a self-killing program in the form of apoptotic or 
autophagic cell death, followed by phagocytosis of cellular remains by, for example, 
macrophages (Edinger and Thompson 2004; Bursch 2004; Green and Kroemer 2004).  
6  
Apoptotic and autophagic cell death are known as PCD type 1 (PCD-1) and PCD type 2 
(PCD-2), respectively (Edinger and Thompson 2004; Bursch, 2004).  
 Apoptosis (or PCD-1) is a form of caspase-dependent PCD. It is a highly regulated 
program of cell death hence this process represents a potential target for therapeutic 
intervention to prevent heart failure. Apoptosis is activated in cardiomyocytes by multiple 
stressors that are commonly seen in cardiovascular disease such as cytokine production 
(Kubota et al. 1997; Bryant et al. 1998), increased oxidative stress (Sayen et al. 2003) and 
DNA damage (Wang et al. 2001). The major pathways involved in apoptotic signaling in 
the heart involve the extrinsic (death receptor pathway) and intrinsic (mitochondrial) 
pathways. Lysosomal enzymes contribute to cell death, suggesting an indirect 
involvement of autophagy.  
 The extrinsic pathway is activated via a complex signal transduction from the 
plasma membrane leading to activation of the caspase cascade. Death receptors belong to 
the TNF/nerve growth factor receptor superfamily. For example, Fas ligand (FasL) -to- 
Fas receptor (FasR) binding causes receptor activation and the recruiting of the Fas-
associated death domain (FADD). This Fas/FADD complex binds and cleaves to pro-
caspase 8 (zymogen) to form active caspase 8. The apoptotic signal is spread through the 
cell via a caspase cascade, in which downstream executioner caspases (3 and 7) are 
activated, and the release of cytochrome c by mitochondria (Thorburn 2004). 
 The primary function of mitochondria is to provide energy for the cell in the form 
of adenosine triphosphate (ATP) through oxidative phosphorylation. However, 
mitochondria can also contribute to cell death in response to intracellular stress such as 
increased oxidative stress, serum deprivation and DNA damage. In response to stress, 
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mitochondria release several pro-apoptotic factors such as cytochrome c, apoptosis 
inducing factor (AIF), endonuclease (Endo) G and second mitochondria-derived activator 
of caspases (SMAC), resulting in the initiation of apoptosis. The intrinsic pathway is 
regulated by pro- and anti-apoptotic B-cell lymphoma (Bcl)-2 proteins. Anti-apoptotic 
Bcl-2 proteins include Bcl-2 and Bcl-xl, which promote cell survival. The pro-apoptotic 
Bcl-2 proteins include Bcl-2–associated X protein (Bax), Bcl-2 homologous 
antagonist/killer (Bak), Bcl-2/adenovirus E1B 19-kDa protein-interacting protein 3 
(BNIP3), Bcl-2-associated death promoter (Bad) and p53 up-regulated modulator of 
apoptosis (PUMA) (Danial and Korsmeyer 2004; Huang and Strasser 2000). 
 Pro-apoptotic Bcl-2 proteins, Bax/ Bak, activate cell death by permeabilizing the 
outer mitochondrial membrane, which releases pro-apoptotic proteins such as cytochrome 
c and AIF from the intermembrane space (Kubli et al. 2008). Anti-apoptotic Bcl-2 has 
been reported to protect against cell death by inhibiting activation of pro-apoptotic Bax/ 
Bak (Gustafsson and Gottlieb 2007). Pro-apoptotic Bcl-2 proteins can sense cellular 
stress and integrate diverse cell death stimuli. For example, BNIP3 is activated in 
response to increased oxidative stress (Kubli et al. 2008), whereas Bad is activated in 
response to growth factor deprivation (Zha et al. 1996). In response to a specific stress, 
activated downstream Bax and/or Bak go on to form of a pore in the outer mitochondrial 
membrane, which allows for release of proteins from the inter-membrane space. 
Activated Bax/Bak can also sequester to and inhibit anti-apoptotic Bcl-2/Bcl-xL 
(Gustafsson and Gottlieb 2007). 
 Cytochrome c, an essential enzyme complex from the electron transport chain in 
mitochondria, bind apoptosis-activating factor 1 proteins to form apoptotic bodies 
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(apoptosomes), which then initiates a cascade of caspase activation (recruits procaspase 
9) and the initiation of apoptosis. The SMAC binds and inhibits the activity of inhibitor 
of apoptisis proteins and is therefore pro-apoptotic. Both the flavoprotein AIF and Endo 
G are translocated to the nucleus where they cause DNA fragmentation into fragments of 
about 50kb and degrade single stranded DNA, respectively (Weinberg 2007). In addition, 
it has been reported that activated caspase 3 translocates to nucleus where it cleaves the 
DNA repairing enzyme, poly (ADP-ribose) polymerase and activates Endos which also 
cleave DNA. These events culminate in apoptotic cell death (Li et al. 1997; Pacher and 
Szabo 2007; de Boer et al. 2000) Moreover, considering the fact that AIF functions as a 
nicotinamide adenine dinucleotide oxidase involved in the complex I of the electron 
transport chain (Vahsen et al. 2004), loss of AIF from mitochondria may cause further 
mitochondrial dysfunction due to reduction in electron transport capacity. Thus, release 
of AIF not only initiates apoptosis, but also subsequently induces mitochondrial 
dysfunction, which will ensure cell death. When caspases are inhibited, injured cells are 
still able to undergo PCD due to mitochondria-to-nucleus translocation of AIF. This 
caspase independent pathway also causes DNA fragmentation and chromatin 
condensation (Daugas et al. 2000). 
 
1.4 Autophagy  
 Autophagy is an intracellular bulk degradation process whereby cytosolic, long-
lived proteins and organelles are degraded and recycled (Levine et al. 2004). Autophagy 
occurs at basal levels but can be further induced by stresses, such as nutrient depletion 
(Lum et al. 2005) and acute ischemia (Takagi et al. 2007, Matsui et al. 2007). This 
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cytoplasmic quality control mechanism removes protein aggregates and damaged 
organelles (Nakai et al. 2007) by autolysosomal degradation of membrane lipids and 
proteins generates free fatty acids and amino acids, which can be reused to maintain 
mitochondrial ATP production and protein synthesis, and promote cell survival. The 
beneficial role of autophagy has been demonstrated in past studies. Inactivation of the 
autophagy related gene protein (Atg) 5 in adult mice has been shown to result in 
myocardial dysfunction (Nakai et al. 2007). However, under certain conditions, 
autophagy also promotes PCD, examples of such conditions include reperfusion (Takagi 
et al. 2007, Matsui et al. 2007), high glucose exposure (Younce et al. 2010), prolonged 
endoplasmic reticulum (ER) stress (Takemura et al. 2006, Younce et al. 2010). Together, 
these results clearly demonstrate that autophagy could be either protective or detrimental 
depending on the nature of the stimuli and the levels of autophagy induced (Kang and 
Avery 2008; Matsui et al. 2007).  
 
1.4.1 Molecular mechanism of autophagy 
 In eukaryotes, the process of autophagy consists of four phases, “induction, vesicle 
nucleation, vesicle expansion and completion and autolysosome formation” (Chen and 
Klionsky 2011). The “induction phase” can be initiated by activation of the Atg1 
complex or beclin-1 (Atg6) (Gustafsson et al. 2009). Followed by “vesicle nucleation,” in 
which Atg’s and lipids are recruited to the phagophore assembly site (PAS) and a Class 
III phosphatidylinositol 3-kinase (PtdIns3K) complex is activated. Higher eukaryotes 
have three types of PtdIns3K (class I, II and III) (Chang and Neufeld 2010). Mammalian 
class III PtdIns3K complex is composed of beclin-1, phosphoinositide-3-kinase class 3 
10  
and phosphoinositide-3-kinase, regulatory subunit 4 (Yang and Klionsky 2010). A Class 
III PtdIns3K complex produces PI3-phosphate, a lipid signaling molecule that is crucial 
in the early stages of autophagosome nucleation. Thirdly, the “vesicle expansion and 
completion” phase consists of phagophore double membrane expansion and enclosing the 
sequestered cytosolic cargos by autophagosome formation (Chen and Klionsky 2011). 
Autophagosomal membrane specific protein light chain 3 (LC3) or Atg8, a marker for 
autophagosome membrane, is cleaved by the cysteine protease Atg4 to expose a glycine 
residue that is then covalently conjugated with phosphatidylethanolamine (PE) thereby 
allowing membrane association. Lipidation of LC3 converts it from its soluble, 
cytoplasmic form (LC3-I) to the membrane-bound, autophagosome-associated form 
(LC3-II), which is required for membrane expansion (Ichimura et al. 2000). Atg proteins 
such as Atg12, Atg5 and Atg16 are covalently conjugated with each other to form the 
Atg12–Atg5–Atg16 complex, which is recruited to the forming autophagosomal 
membrane and required for elongation of the isolation membrane. This third phase is a 
process that requires the two ubiquitin-like conjugation steps, of Atg5–Atg12 and LC3-
II–PE, in order to proceed. Conjugation reactions of Atg12 and Atg8 are catalyzed by the 
E1-like enzyme, Atg7 (for activation), and the E2-like enzymes, Atg10 (for Atg12) and 
Atg3 (for Atg8) (Geng and Klionsky 2008). The presence, in the preautophagosome, of a 
protein complex that includes an autophagy-specific class III PtdIns3K complex is 
necessary to localize the conjugation systems to the forming autophagosome (Kihara et 
al. 2001). Lastly, the “autolysosome formation” phase, in which the completed 
autophagosome fuses with a lysosome to form an autolysosome that degrades the cargos 
by using degradation and the products are released back into cytosol, through permeases, 
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for reuse (Klionsky 2007). 
   
1.4.2 Regulation of autophagy  
A study by Kim et al. (2011) provides molecular insights into how 5’- adenosine 
monophosphate activated protein kinase (AMPK) and mammalian target of rapamycin 
complex 1 (mTORC1) regulate autophagy through coordinated phosphorylation of Unc-
51-like kinase (Ulk) 1/2, examples of fundamental autophagic machinery. AMPK is 
shown to sense the cellular energy status and activate Ulk1 kinase by a coordinated 
cascade. Under glucose starvation (4h), the activated AMPK inhibits mTORC1s Ser 757 
phosphorylation of Ulk1, leading to Ulk1-AMPK interaction. AMPK then phosphorylates 
Ulk1 on Ser 317 and Ser 777, activates Ulk1 kinase and eventually leads to autophagy 
induction. Although AMPK may phosphorylate additional sites that may contribute to 
Ulk1 activation, phosphorylation of Ser 317/Ser 777 is required for Ulk1 activation and 
efficient autophagy induction in response to glucose starvation. By overexpression of Ras 
homolog enriched in brain (Rheb), the mTORC1 activator, Kim et al. (2011) showed 
mTORC1 to inhibit Ulk1 activation by phosphorylating Ulk1 Ser 757 and disrupting its 
interaction with AMPK. However, it is worth noting that inhibition of mTORC1 by 
amino-acid starvation or rapamycin (mTOR inhibitor) treatment can activate Ulk1 in an 
AMPK-independent manner as these conditions are sufficient to activate Ulk1 and induce 
autophagy, but do not activate AMPK (Kim et al. 2011).  
Overall different protein complexes assemble in the pre-autophagosome when 
autophagy is activated. Assembly in the pre-autophagosome of conjugation cascades and 
phosphorylation systems leads to the nucleation/elongation of the isolation membrane. 
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Progression of this isolation membrane toward the formation of an autophagosome is 
regulated through the mammalian target of rapamycin (mTOR)-regulated signaling 
pathway.  
 Autophagy is also regulated by insulin, various growth factors and conditions that 
lead to reduced intracellular levels of ATP, because sequestration, fusion and degradation 
are energy-dependent mechanisms (Ohshita 2000). The effect of some physiological 
regulators depends on the tissue analyzed. For example, glucagon and beta-adrenergic 
agonists inhibit rather than stimulate autophagy in cardiac and skeletal muscle, and the 
inhibitory effect of amino acids is not observed in pancreatic cells (Telbisz and Kovacs 
2000). 
 
1.4.3 Autophagy during ischemia and reperfusion 
  In a model of ischemia/reperfusion (I/R), the cellular ATP content decreases with 
ischemia and rapidly recovers after reperfusion, causing autophagosome formation to be 
stimulated serially, in two distinct conditions, namely energy-starved and energy-
unstarved conditions (Takagi et al. 2007). Matsui et al. (2007) observed an increase in 
autophagy levels within 20 minutes of ischemia in the mouse heart in vivo and a further 
increase during the reperfusion phase. Decker and Wildenthal (1980) demonstrated that 
hypoxic conditions for 40 minutes led to an increase in autophagic vacuoles, and that 
reperfusion after either 20 or 40 minutes of hypoxia induced a dramatic enhancement of 
autophagy in the perfused rabbit heart (Decker and Wildenthal 1980). Autophagy has 
also been observed in human and pig hearts under chronic myocardial ischemia (Elsasser 
et al. 2004; Yan et al. 2006). 
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  Autophagy may serve primarily to maintain energy production during acute 
ischemia but switch to clearing up damaged organelles during chronic ischemia or 
reperfusion (Matsui et al. 2007; Takagi et al. 2007). Autophagy has been shown to be 
protective, in cardiac myocytes, during glucose deprivation or ischemia (Matsui et al. 
2007). During myocardial ischemia (an energy starved state) the activation of AMPK 
leads to the induction of autophagy (Arad et al. 2007). 
  AMPK is no longer activated during reperfusion, the further increase in autophagy 
during the reperfusion phase is unlikely to be mediated by AMPK-dependent 
mechanisms (Matsui et al. 2007). Beclin-1 upregulation, in heart (Matsui et al. 2007), 
brain (Chien et al. 2007) and kidney cells (Rami et al. 2008), was found to mediate 
autophagy in the reperfusion phase. It has been proposed that the AMPK-dependent 
signaling mechanism mediates autophagy during glucose deprivation or ischemia, 
whereas in the reperfusion phase, beclin-1 mediates autophagy even after the energy 
supply and the activity of mTOR are restored (Matsui et al. 2007; Takagi et al. 2007). 
 The inhibition of beclin-1-dependent autophagy was found to be protective during 
I/R in vivo and cell viability in response to H2O2 is increased, in vitro. It may be that 
mTOR (inhibition)-independent and beclin-1-dependent autophagy, when cells are not in 
a starved condition, could be a detrimental process in contrast to the energy-recovering 
process during starvation which is essential for survival. However the remarkable 
upregulation of beclin-1 may mean that over-activation of autophagy could just be 
detrimental to the cell. Thus, specific modulation of autophagy, such as stimulation of 
AMPK or inhibition of beclin-1, might be a novel strategy to enhance survival under 
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ischemia and protect against cardiac myocyte death from reperfusion injury in vivo 
(Matsui et al. 2007; Takagi et al. 2007).   
 Multiple molecular reasons could explain as to why autophagy is detrimental in the 
reperfusion phase. Firstly, the hyperactivation of autophagy has been shown to cause cell 
death (Maiuri et al. 2007). Lysosomal enzymes are upregulated in the heart after 
myocardial infarction (Mayanskaya et al. 2000). Plus dramatic beclin-1 and BNIP3 
induction leads to autophagy at supra physiological levels during reperfusion. Secondly, 
due to the inhibitory effect of Bcl-2 on beclin-1 activity, whether autophagy leads to cell 
death or survival may depend on balance between Bcl-2 and beclin-1 (Pattingre et al. 
2005). Downregulation of Bcl-2 or upregulation of Bcl-2/Bcl-xL binding proteins, such 
as BNIP3, during the reperfusion phase would stimulate apoptotic and autophagic cell 
death via beclin-1 activation (Grunenfelder et al. 2001). Thirdly, common mediators of 
autophagy and apoptosis may play a role during I/R. For example, calpains, which cleave 
Atg5 and promote apoptosis, are upregulated during I/R (Pyo et al. 2005). 
 
1.4.4 Oxidative stress can cause autophagy 
 At a low level of oxidative stress, autophagy protects the cell against major harm 
by degrading damaged mitochondria before cytochrome c release occurs. However, 
prolonged or severe oxidative stress can damage cellular molecules or organelles and 
promote cell death via apoptotic and autophagic cell death (Kiffin et al. 2006). Damaged 
lysosomes are unable to fuse with autophagosomes containing damaged components. 
Instead these lysosomes release potent hydrolases and enhance the degree of cellular 
damage. Augmented autophagy increases the sensitivity of cells to oxidative stress and 
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hence contributes to the damaged lysosome-induced generation of ROS. Inhibitors of 
autophagy, chloroquine or 3-methyladenine prevent ROS formation (Kubota et al. 2010).  
In addition, Ha et al. (2010) demonstrated oxidative stress-induced autophagic cell death 
in cardiac H9c2 cells incubated in H2O2 (1 mM, 24h) (Ha et al. 2010). This was reversed 
by treatment with propofol, an antioxidant, (Ha et al. 2010).  
 Nutrient deprivation (Scherz-Shouval et al. 2007), I/R, hypoxia (Wu et al. 2009) 
and responses to cell stress (Azad et al. 2009; Moore et al. 2007) all result in increased 
ROS generation and oxidative stress, which stimulate autophagy. Prolonged nutrient 
deprivation increases mitochondrial derived H2O2 via a PI3K/beclin-1 dependent 
pathway. The resultant ATG4 oxidation and inhibition promotes ATG8-PE conjugation 
and hence increased autophagy (Scherz-Shouval et al. 2007).  
 
 1.4.4.1 Ischemia/reperfusion 
 During ischemia, the enzyme xanthine oxidase (XO) forms and XO substrates 
(xanthine and hypoxanthine) accumulate (Chambers et al. 1985). During reperfusion 
when oxygen (O2) is present, xanthine and hypoxanthine are depleted and XO-mediated 
O2•¯ generation occurs (Misra et al. 2009). A number of reasons could explain the 
triggering of autophagy in the reperfusion phase. Even though the lack of ATP is 
alleviated, autophagy is still triggered. This may be explained by ROS production. 
Mitochondrial ROS production is amplified by ROS-induced ROS release when electron 
transport resumes during reperfusion (Zorov 2006). Damaged proteins and organelles and 
lipid peroxidation in mitochondria, due to ROS, promote autophagy (Djavaheri-Mergny 
et al. 2006). Autophagy can target CAT for degradation, this causes accumulation of 
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H₂O₂, hence autophagy and oxidative stress can initiate a positive feedback mechanism 
and cause autophagic cell death (Scherz-Shouval and Elazar 2007). Another explanation 
may be due to cellular stresses, such as oxidative stress, that impair ER functions. The 
accumulation of misfolded proteins leads to ER stress and the unfolded protein response 
(UPR). If prolonged, this can trigger protective autophagy (Ogata et al. 2006; Kouroku et 
al. 2007). ER stress and the UPR will be introduced in more detail later. 
 
1.5 Mammalian cell cross-talk: autophagy and apoptosis. A Cooperative and/or 
negative feedback relationship 
  This section will focus on the cross-talk between the autophagic and apoptotic 
pathways. Under certain conditions, autophagy and apoptosis are two independent 
processes (Eisenberg-Lerner et al. 2009), whereas in other situations, the activation of 
autophagy inhibits apoptosis (Maiuri et al. 2007) or autophagy occurs upstream of 
apoptosis (Eisenberg-Lerner et al. 2009).  
 Both apoptosis and autophagy can cooperate to lead to cell death. They may occur 
simultaneously and even cooperatively, although one may predominate and therefore 
hide evidence of the other. Alternatively, the second pathway may only be activated upon 
the impairment/inhibition of the first pathway, it takes over to ensure efficient cell death. 
The cooperativity and/or negative feedback imply that there is coordination between the 
pathways (Eisenberg-Lerner et al. 2009). Etoposide, a cytotoxic chemotherapy drug, has 
been shown to induce both apoptosis and autophagy, in mouse embryonic fibroblasts 
(MEFs) (Feng et al. 2005). And autophagy is significantly induced when apoptosis is 
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blocked by the expression of Bcl-2, following ER stress, in cultured MEFs (Gozuacik et 
al. 2008). 
 In some cases, autophagy enhances apoptotic cell death and is required for the latter 
(Eisenberg-Lerner et al. 2009). Autophagy and apoptosis are sequentially observed in 
light-damaged retinas in the intact mouse or H2O2-treated photoreceptor cells, treatments 
that induce oxidative stress. Autophagy can function both upstream of apoptosis and 
independently leads to cell death. Inhibition of apoptosis accelerated the induction of 
autophagy markers and only partially attenuated cell death. Caspase 3 activation and 
apoptosis were dependent on the release of cathepsin B from an endosomal/ lysosomal 
compartment, suggesting a possible molecular link between autophagy and apoptosis 
(Kunchithapautham et al. 2007). 
 Under other circumstances, autophagy is restrained by the apoptotic pathway and is 
evident only when the latter is inhibited (Eisenberg-Lerner et al. 2009). For example, 
autophagic cell death mediated by the receptor-interacting protein and c-Jun N-terminal 
kinase (JNK), stress kinase, was activated upon inhibition of caspase 8 (Yu et al. 2004). 
In all of the diverse situations described above, apoptosis, autophagy or both are used to 
eliminate the cell (Eisenberg-Lerner et al. 2009).  
 
1.6 High glucose-induced oxidative stress in apoptosis and autophagy 
 
1.6.1 High glucose-induced oxidative stress and its role in multiple pathways 
 High glucose toxicity is an important initiator of cardiovascular disease, 
contributing to the development of cardiomyocyte death and diabetic complications (Yu 
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et al. 2008). Increased ROS production is observed in type 1 and type 2 diabetes and is 
considered to be a major contributing factor in the development of diabetic 
cardiomyopathy (Desco et al. 2002; San Martin et al. 2007). Multiple pathways have 
been linked to hyperglycemia-induced oxidative stress. In hyperglycemia associated with 
diabetes mellitus, there is activation of the polyol pathway, hexosamine pathway, protein 
kinase C and increased advanced glycation end products (Nishikawa et al. 2000; 
Farahmand et al. 2003; Defraigne 2005). Under normal metabolic circumstances, 2%–5% 
of glucose entering a cell is processed through the hexosamine pathway (Marshall et al. 
1991). During high glucose exposure, excess glucose is directed into the hexosamine 
pathway in which the end product is UDP-N-acetylglucosamine that acts as substrate for 
glycosylation of vital intracellular factors (McClain and Crook 1996). Active protein 
kinase B (Akt) phosphorylates and activates endothelial NO synthase (eNOS). The 
hexosamine pathway attenuates Akt and impairs eNOS activity (Federici et al. 2002). 
Chemical inhibition of NOS in diabetic and nondiabetic rats increases sorbitol 
accumulation in the aorta by the polyol pathway, while treatment with L-arginine (an NO 
precursor) or nitroglycerine prevents this accumulation. This suggests that increased NO 
production or bioavailability may protect against diabetes-induced complications in the 
polyol pathway (Ramana et al. 2003). Inappropriate activation of these important 
regulatory molecules can have deleterious effects on cellular functions and is thought to 
contribute to the pathogenesis of various diabetic vascular complications (Son 2007). 
 Atherogenic mechanisms also appear to be involved in pathophysiology of 
diabetes-associated heart disease. Several atherogenic mechanisms, such as low-density 
lipoprotein (LDL) oxidation, endothelial dysfunction, and vascular smooth muscle cell 
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(VSMC) proliferation and migration, could be induced by oxidative stress, leading to 
cardiomyopathy. There is an upregulation of lectin-like oxidized LDL (oxLDL) receptor 
in hyperglycemic conditions, which enhances the effect of oxLDL signaling and 
facilitates foam cell formation from macrophages (Chakravarti et al. 1991). 
Hyperglycemia-induced ROS have also been shown to increase monocyte adhesion, 
levels of adhesion molecules, VSMC migration and the secretion of platelet derived 
growth factor (Devaraj et al. 2004). 
 Increased oxidative stress may lead to the formation of gene products that cause 
cellular damage, thereby contributing to the pathogenesis of various diabetic vascular 
complications (Son 2007; Newsholme et al. 2007). Tyrosine phosphatases, encoded by 
more than 100 genes in the human genome, play an important role in tissue inflammation, 
cell development, cellular growth, and control of cell survival involving oxidative stress 
(Chong and Maiese 2007). Two of these phosphatases, Anti-Src Homology Phosphatases 
1 and 2 are important for many growth factors and metabolic pathways implicated in 
certain diseases, such as diabetes, cancer, and neurodegenerative disorders. In cultured 
VSMC’s exposed to high glucose levels as well as in vascular tissues from animals and 
patients with diabetes, there were significantly increased levels of oxidants such as 
glycated compounds, oxLDL, O2•¯, nitrotyrosine and markers of oxidative changes in 
proteins, lipids, and DNA (Son 2007). 
High glucose is known to lead to the increased production and activation of 
angiotensin II (Ang II) signaling pathways in cardiomyoyctes (Singh et al. 2007). 
Activation of Ang II signaling has been shown to result in monocyte chemotactic protein 
(MCP) -1 production, a pro-inflammatory cytokine, in cardiac fibroblasts (Omura et al. 
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2004). Like MCP-1, glucose-induced Ang II can induce NADPH oxidase-mediated ROS 
production (Kimura et al. 2005).  
In addition, Yu et al. (2010), demonstrated the induction of apoptosis, in vitro, in 
H9c2 cells incubated in high glucose (25 mM, after 96h), with time-dependent DNA 
fragmentation and cell loss. Insulin-like growth factor 1 (IGF-1), a survival factor, exerts 
its bioactivity via binding to IGF-1 receptor (IGF-1R). Insulin-like growth factor 1 
receptor-dependent signaling is crucial for the survival of many cell types, including rat 
cardiomyocyte H9c2’s (Yu et al. 2008). Histone de-acetylation, by histone deacetylases 
(HDACs), down regulates gene expression (Juan et al. 2000). The tumour suppressor 
protein, p53, is a critical regulator of apoptosis and transmits signals to genes that control 
apoptosis when cells are under stress. Several studies indicate that IGF-1R expression is 
regulated by p53 (Liu et al. 2009). High glucose treatment repressed IGF-1R transcription 
and protein expression after 24h and 48h respectively. It is proposed that this high 
glucose-induced IGF-1R repression is mediated by p53 and IGF-1R promoter association 
and by the subsequent high glucose-dependent p53 enhanced recruitment of chromatin-
modifying proteins, such as HDAC1, to the IGF-1R promoter–p53 complex. 
Transcriptional repression of IGF-1R promoter results due to the de-acetylation and 
prevention of histone-4 associating with IGF-1R promoter.  This suggests that enhancing 
acetylation of histone 4 and IGF-1R expression may be a useful strategy to prevent 
diabetic cardiomyopathy (Yu et al. 2010). 
 
1.6.2 High glucose-induced endoplasmic reticulum stress and programmed cell death  
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  High glucose exposure (28 mM D-glucose) can induce ER stress in H9c2 
cardiomyocytes (Younce et al. 2010; Younce et al. 2010i). The ER is responsible for the 
synthesis and folding of newly translated protein. ER stress is when the balance between 
the import of new unfolded proteins and the secretion of folded mature proteins is 
disturbed. Cells initially cope with ER stress through the UPR, a mechanism which 
attempts to relieve the ER burden by inhibiting global protein translation and thereby 
reducing the amount of proteins entering the ER, increasing degradation of 
misfolded/unfolded proteins and enhancing the ER folding capacity (upregulating protein 
chaperones). These UPR responses are mediated, respectively, through activation of the 
ER-resident transmembrane proteins, protein kinase RNA-activated-like ER kinase 
(PERK), inositol-requiring enzyme 1 (IRE1) and activating transcription factor 6 (ATF6) 
(Jing et al. 2012).  
  ER stress-induced cardiomyoycte apoptosis has been reported to occur in the hearts 
of diabetic animals (Li et al., 2008). Oxidative stress, hyperglycemia, hypoxia and 
inflammatory factors can disturb ER function and compromise the adaptive UPR, 
resulting in persistent ER stress and eventually apoptotic cell death (Jing et al. 2012). 
When the UPR is prolonged, apoptosis is activated via the pro-apoptotic transcription 
factor CCAAT/enhancer binding protein- homologous protein (CHOP), JNK and/or 
caspase 4-mediated mechanisms (Szegezdi et al. 2003; Schroder et al. 2005). IRE1α 
induces stress kinases JNK and p38, which in turn can result in an increase in pro-
apoptotic proteins such as p53 and PUMA and eventually cell death (Zhang et al. 2008; 
Younce et al. 2010i).  
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Prolonged ER stress is also known to cause the induction of autophagy that is 
known to be involved in cardiovascular diseases (Takemura et al. 2006). Although 
autophagy is thought at first to protect the cell from increased stress (Boya et al. 2005) it 
is known that prolonged autophagy can lead to cell death (Martin et al. 2004). In 
mammalian cells the accumulation of misfolded proteins leads to the activation of ER 
stress sensors, such as PERK and IRE1, which stimulates protective autophagy (Ogata et 
al. 2006; Kouroku et al. 2007). 
Diabetes is associated with elevated serum levels of MCP-1, a pro-inflammatory 
cytokine (Mine et al. 2006). MCP-1 induces a novel zinc-finger protein, MCP-1-induced 
protein (MCPIP) (Zhou et al. 2006). MCPIP-induced ROS/reactive nitrogen species 
production induces ER stress, which leads to autophagy and apoptosis through caspase 2 
and 12, ER-related caspases and an IRE1α -JNK/p38-p53-PUMA pathway (Younce et al. 
2010i). 
  2-Deoxy-D-glucose (2-DG) is a glucose analog that interferes with glycolysis by 
blocking the first two reactions in this pathway carried out by hexokinase and phospho-
glucose isomerase (Wick et al. 1957). Due to its structural similarity to mannose, 2-DG 
interferes with oligosaccharide synthesis leading to abnormal N-linked glycosylation 
(Datema et al. 1978) resulting in ER stress. Xi et al. (2010), showed that in aerobic 
conditions, autophagy is upregulated in multiple human cancer cell lines in response to 2-
DG and is accompanied by ER stress and UPR signaling as well as decreased cellular 
ATP levels. In contrast they showed that cells grown under anaerobic conditions undergo 
a more severe drop in ATP levels, 2-DG decreases autophagy even below basal levels, 
accompanied by a decrease in the ER stress/UPR marker, glucose-regulated protein (Grp) 
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78, an ER lumen protein. Their study also demonstrated that the autophagy was of a 
protective nature. The upregulation of autophagy promoted cancer cell survival against 2-
DG-induced cytotoxicity by reducing 2-DG-induced ER stress. Inhibition of 2-DG-
induced autophagy leads to increased levels of ER stress/UPR markers as well as 
apoptosis (Xi et al. 2010). 
 
1.7 The effects of high glucose on hypoxia-induced programmed cell death 
  Under hypoxia and anaerobic conditions, oxidative phosphorylation in 
mitochondria is inhibited or reduced and hence cells rely mainly on glycolysis for energy 
production (Maher et al. 2004). Hypoxia results in increased ROS generation and 
oxidative stress, which stimulate caspase-dependent (apoptosis) (Shimizu et al. 1996) and 
caspase-independent PCD (autophagy) (Matsui et al. 2008; Wu et al. 2009).  
 
1.7.1 The hypoxia-inducible factor (HIF)-1  
  The hypoxia-induced O2 sensing transcription factor, HIF-1, can be influenced by 
cellular ROS generation and highly regulated by cellular O2 tension. The HIF-1 is found 
to be consisting of a dimer of subunits HIF-1α and HIF-1β. In normal conditions, HIF-1α 
is hydroxylated at the proline residues (402 and 564), catalyzed by O2-dependent prolyl 
hydroxylase enzymes (Hirota and Semenza 2005; Jaakkola et al. 2001). The tumor 
suppressor von Hippel-Lindau protein specifically binds with hydroxylated HIF-1α and 
promotes its ubiquitylation and proteolysis (Jaakkola et al. 2001), whereas HIF-1β is 
found to be constitutively expressed. In response to hypoxia, HIF-1α is not hydroxylated 
at the proline residues and therefore is stabilized. The stabilized HIF-1α translocates into 
24  
the nucleus and binds to HIF-1β and thus forms the HIF-1 complex, which binds to 
hypoxia response element (HRE, 5’-RCGTG-3’) to increase the transcription of pro-
survival-hypoxia-regulated genes by causing their transactivation. Examples of such 
hypoxia-regulated genes include vascular endothelial growth factor (VEGF) and hence 
angiogenesis, GLUT1 thereby enhancing glycolysis and erythropoietin for erythropoiesis 
(Hirota and Semenza 2005). HIF-1α is thought to be a crucial regulator of hypoxia-
adaptational responses (Semenza 2000). 
 
1.7.2 The effect of the hypoxia-inducible factor -1 on cardiac cell survival 
Both hyperglycemia and hypoxia have been suggested to be important causative 
factors for diabetic retinopathy (Bursell et al. 1996), neuropathy (Newrick et al. 1986), 
arteriosclerosis (Santilli et al. 1993). High glucose (22 mM) levels suppress serum 
deprivation-induced apoptosis in VSMC by up-regulating expression of Bcl-2 and Bcl-
xL, suggesting that enhanced expression of anti-apoptotic proteins may play an important 
role in the development of macrovascular complications in diabetes (Li et al. 2005). 
During hypoxia, cells shift to a mainly glycolytic form of metabolism by up-regulating 
HIF-1α-dependent glycolytic genes such as GLUT-1 transporters (Semenza 2003), 
phosphoglycerate kinase 1 (Chen et al. 2001) and hexokinase 1 (Gao et al. 2004), thereby 
decreasing intracellular pH and increasing lactic acid accumulation that triggers apoptosis 
(Schmaltz et al. 1998).  
In addition, Malhotra et al. (2008) showed that HIF-1α potentiates apoptosis 
under hypoxic conditions in rat H9c2 cells. Hypoxia-induced apoptosis in H9c2 cells 
were found to be markedly suppressed by knockdown of HIF-1α. Overexpression of wild 
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type HIF-1α had little effect in H9c2 cells, suggesting that levels of HIF-1α in these cells 
during hypoxia were already sufficient to maximally trigger apoptosis. In H9c2 cells 
overexpression of HIF-1α had little effects on apoptosis, but reduction of HIF-1α 
inhibited apoptosis. Expression of HIF-1α is also associated with enhanced Bax 
activation in these systems thereby providing a mechanistic link between hypoxic stress 
and apoptosis in H9c2 cells (Malhotra et al. 2008).  
Hypoxia has also been shown to activate the UPR in cardiac myocytes (Thuerauf 
et al. 2006) which may potentially protect the myocardium during hypoxic stress, but in 
the case of prolonged or unresolved ER stress the UPR can also activate apoptotic 
(Rutkowski et al. 2004) or autophagic cell death (Younce et al. 2010i).  
  However the opposite effects have also been demonstrated, enhanced glycolytic 
metabolism and GLUT1 expression have been shown to markedly attenuate hypoxia-
induced apoptosis via reduced mitochondrial release of cytochrome c and activation of 
caspase 9 (Malhotra and Brosius 1999; Lin et al. 2000). Enhanced glycolytic metabolism 
and GLUT1 expression also suppress levels of HIF-1α in hypoxic cardiomyocytes (H9c2 
cells) due to enhanced HIF-1α proteosomal degradation (Malhotra 2002).  
   
1.7.3 Hypoxia-induced oxidative stress and the hypoxia-inducible factor -1  
 It has been reported HIF-1 activity is influenced by cellular ROS generation. 
Mitochondria produce a burst of ROS in response to hypoxia and that this burst is 
necessary and sufficient to activate HIF-1 (Guzy et al. 2005; Mansfield et al. 2005). In 
addition to hypoxic conditions, HIF-1 is also activated in normoxic conditions by 
physiological stimuli like insulin (Zelzer et al. 1998). Insulin is known to increases 
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intracellular ROS generation to regulate the post-translational translocation of GLUT4 
(Mahadevet al. 2001), it also increases the expression of GLUT1 and phosphoglycerate 
kinase-1. Insulin increases the transcription of many of its target genes, such as VEGF, 
Epo and endothelin-1 by activating HIF-1 (Hirota and Semenza 2005; Zelzer et al. 1998). 
Biswas et al. (2007) demonstrated that insulin-stimulated ROS generation, particularly 
H2O2, by NADPH oxidase is essential for the activation of HIF-1 in insulin-sensitive 
hepatic cells HepG2 and cardiac myoblasts H9c2. They also found that, in HepG2 cells, 
the NADPH oxidase-generated ROS regulates phosphorylation of tyrosine residues of 
insulin receptor tyrosine kinases as well as PtdIns3K activity, essential for HIF-1 
activation and subsequent expression of genes like VEGF and GLUT1 (Biswas et al. 
2007). 
  The HIF-1α exerts both anti-apoptotic and pro-apoptotic effects, depending on the 
cell type (Piret et al. 2002). Activation of HIF-1α by a redox-senstive pathway has also 
been shown to promote mitochondrial cell death pathway by upregulating BNIP3 (Zhang 
et al. 2007), Bad and Bax (Bruick 2000; Merighi et al. 2007; chen et al. 2005). BNIP3, a 
Bcl-2 pro-apoptotic protein, was identified to contain the binding sites for HIF-1α in its 
promoter region (Sowter et al. 2001). The BNIP3 gene product induces apoptosis by 
binding and inhibiting the anti-apoptotic proteins Bcl-2 and Bcl-xL (Greijer and Wall 
2004). Interestingly, BNIP3 is localized at the mitochondria. In cases of prolonged 
hypoxia, the HIF-1 complex promotes mitochondrial apoptotic cell death in ventricular 
cardiac myocytes by significant induction of BNIP3 (Regula and Kirshenbaum 2002) or 
by stabilizing the tumor suppressor protein p53 (An et al. 1998). In addition to apoptosis, 
BNIP3 can induce autophagy by inducing mitochondrial dysfunction, activating beclin-1 
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activity by titrating Bcl-2 and/or Bcl-XL away from beclin-1 (Tracy et al. 2007) or by 
binding and inhibiting Rheb, the promoter of mTOR activity (Li Y et al. 2007). 
  Zhou et al. (2010) studied apoptosis in primary neonatal rat ventricular myocytes 
(NRVM) which were subjected to 24h of hypoxia. Their study also showed hypoxia to 
increase the expression levels of both HIF-1α and pro-apoptotic protein BNIP3 and hence 
the rate of apoptosis. The degree of both HIF-1α expression and apoptosis in hypoxia 
exposed NRVM depends on the degree of hypoxia. When HIF-1α activity is inhibited by 
3-(5′-hydroxymethyl-2 - furyl)-1-benzyl indazole (YC-1) treatment, the level of HIF-1α 
expression decreased. There was also a corresponding decrease in the level of BNIP3 
protein expression and the hypoxia-induced rate of apoptosis. This demonstrates that 
HIF-1α mediated apoptosis in primary NRVM cultured under acute hypoxic conditions, 
and that the pro-apoptotic protein BNIP3 may be one of the key molecules involved in 
this effect of HIF-1α (Zhou et al. 2010).  
 Ornoy et al. (2010) found that 5 and 7 mg glucose/ml (27.8 mM and 38.9 mM 
glucose, respectively) culture medium produces embryonic damage and enhanced 
oxidative stress as well as increased HIF-1α in 10.5-day-old rat embryos and their yolk 
sacs, thus pointing to the possibility that hyperglycemia may also cause hypoxia. In 
addition, reduced O2 levels in the culture medium to 15 or 10% (instead of the normoxic 
20%) also induces anomalies in the cultured embryos and, similarly to hyperglycemia, 
also increases HIF-1α levels in the malformed embryos and their yolk sacs (Ornoy et 
al.2010).  
  It is clear that hyperglycemia can induce oxidative and nitrosative stress in 
many cell types (Yoh et al. 2008). Diabetic state is associated with increased oxidative 
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stress, which plays an important role in the development of diabetic complications. 
Indeed, several studies have reported that hyperglycemia stimulates the production of 
advanced glycosylated end products, activates protein kinase C, and enhances the polyol 
pathway leading to increased O2•¯ formation (Brownlee 2001; Ceriello 2003). O2•¯ 
interacts with NO, forming the potent cytotoxin peroxynitrite, which attacks various 
biomolecules in the vascular endothelium, VSM and myocardium, leading to 
cardiovascular dysfunction (Pacher and Szabó 2006). 
Moreover, high glucose-induced increase in ROS can attenuate the activity of 
HIF-1α, under hypoxic conditions. In contrast in normoxia, ROS can stabilize HIF-1 and 
enhance HIF-1- dependent gene expression (Li et al. 2010). Gao et al. (2007) examined 
the effects of hyperglycemia (25 mM D-glucose and 5.5 mM control, 5 days) in VSMCs, 
under normoxic (5% carbon dioxide (CO2), 95% air) and chronic hypoxic (2% O2, 5% 
CO2, 93% nitrogen (N2)) conditions. Gao et al. (2007) observed high glucose (25 mM) 
levels (mimicking hyperglycemia of diabetes) to attenuate hypoxia-induced apoptosis in 
bovine aortic smooth muscle cells (BASMC). Hypoxia caused a decrease in anti-
apoptotic protein, Bcl-xL expression but this was attenuated by simultaneous high 
glucose (25 mM) and hypoxia. Both pro-apoptotic protein BNIP3L (Bcl-xL suppressor) 
and HIF-1α expression is increased hypoxia but then attenuated in simultaneous high 
glucose (25 mM) and hypoxia conditions. This reduction in HIF-1α resulted in a 
diminished level of HRE-dependent promoter activity concomitant with a decrease in 
BASMC apoptosis. These data confirm the important link between hyperglycemia and 
hypoxia since the glucose-mediated recovery from hypoxia-induced apoptosis was 
significantly attenuated following HIF-1α knockdown (Gao et al., 2007). Mammalian 
29  
cells require a constant supply of O2 to maintain energy balance and sustained hypoxia 
can result in cell death (Hochachka et al. 1996). In addition, blood glucose has been 
shown to be in linear relation with fatal outcome after an acute hypoxic challenge, such 
as acute myocardial infarction (Malmberg et al. 1999). Taken together these studies 
suggest a potential deleterious influence of hyperglycemia on the tissue's capacity to 
adapt to low O2 tensions and that hyperglycemia interferes with the growth response of 
VSMC and cardiomyocytes to hypoxia, further suggesting a new mechanism for the 
development of chronic vascular complications of diabetes.   
As mentioned earlier VEGF is a hypoxia-regulated gene (Hirota and Semenza 
2005). Kim et al. (2002) studied VEGF production by using human renal proximal 
tubular epithelial cells (RPTEC) and rat glomerular epithelial cells (GEC) exposed to 
hypoxia (24h) and/or high D-glucose (30 mM, 24h). Their control cells were cultured 
under normoxic and euglycemic (5 mM) conditions (Kim et al. 2002). Kim et al. (2002) 
found that VEGF mRNA and protein expression after hypoxia were increased in both 
RPTEC and GEC and it’s suggested that it was this VEGF induction that enhanced 
capillary formation in culture (Kim et al. 2002). Hypoxia is a well-established potent 
stimulus for VEGF production in some cells, acting by inducing transcription of VEGF 
gene and stabilization of VEGF mRNA (Minchenko et al. 1994; Levy et al. 1996). GEC 
incubated in high glucose showed an increase of VEGF protein expression only, whereas 
there was an increase of both VEGF mRNA and protein expression in RPTEC. When 
high D-glucose and hypoxia were combined, VEGF mRNA and protein expression was 
higher than control in both cell types (except that mRNA was unchanged in GEC) but 
there were no additive effects of high D-glucose and hypoxia. Overall, Kim et al. (2002) 
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showed VEGF production is dramatically upregulated by hypoxia and by high glucose 
alone and that VEGF secreted by proximal tubular epithelial cells support angiogenesis in 
culture. They also observed that a hyperglycemic, although also stimulatory for VEGF 
production, fails to augment angiogenesis environment, suppresses hypoxia-induced 
angiogenesis (Kim et al. 2002). 
An interesting question is whether hyperglycemia produces hypoxia through the 
known changes in glucose metabolism or hypoxia is the result of hyperglycemia- 
produced oxidative stress. The induction of diabetes has also been shown to produce 
arterial wall hypoxia preceding the formation of atherosclerotic lesions in an animal 
model of diabetes (Santilli et al. 1993). This observation suggests a role for local hypoxia 
in the initiation and/or development of vascular disease in diabetes (Bjornheden et al. 
1999). Chandel et al. (1998) noted, while using wild-type Hep3B cells, that mitochondrial 
enhanced oxidative stress (as observed in diabetes) trigger hypoxia-induced transcription 
of several genes, thus pointing to the possibility that oxidative stress causes hypoxia. 
Catrina et al. (2004) showed, using cultured adult human dermal fibroblasts cells and 
human dermal microvascular cells, that elevated glucose concentrations in the culture 
medium inhibited, in a dose dependent manner, the upregulation of HIF-1α induced by 
hypoxia (1% O2) (Catrina et al. 2004). Moreover, when they studied by 
immunohistochemistry the level of HIF-1α in skin biopsies from ulcers (thus suffering 
from hypoxia) in chronic diabetics or following venous thrombosis in non-diabetic 
patients, they found lower HIF1α levels in the biopsies from the diabetic patients 
compared to the skin from venous thrombosis ulcers (Catrina et al. 2004). Taken 
together, these findings imply that diabetic hyperglycemia may cause hypoxia and 
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excascerbate hyperglycemia-induced damage. High glucose levels, in addition to causing 
hypoxia may also interfere with the normal response to hypoxia.  
 
1.8 The effects of high glucose on hypoxia-induced activation of 5’-Adenosine 
monophosphate protein kinase 
  The AMPK, a serine-threonine kinase, is a heterotrimer protein composed of three 
subunits, alpha, beta and gamma (Hardie et al. 2003). This kinase, which appears to 
function as a “sensor” of the energy status of cells, becomes phosphorylated and activated 
in response to conditions associated with increased intracellular AMP concentration 
(decreased ATP), changes that are present during hypoxia or inhibition of oxidative 
phosphorylation (Abbud et al. 2000; Corton et al. 1994). 
  The α-subunit is the essential part of AMPK with kinase activity. The kinase 
domain is on the N-terminus of the α-subunit and the β-subunit-binding domain is on the 
C-terminus. If a Thr172 in the kinase domain is phosphorylated by an upstream kinase 
(AMPK kinase), kinase activity is increased (Hardie et al. 2005). Dephosphorylation by 
protein phosphatase-2C inactivates AMPK. In the α-subunit, there is an auto-inhibitory 
domain that inhibits its kinase activation. The β-subunit is the binding platform between 
α and γ subunits (Nagata and Hirata 2010; Steinberg et al. 2006). The γ-subunit has four 
cystathionine β-synthase (CBS) domains having avidity with AMP/ATP. If γ binds to 
ATP, it enters a locked state. But the binding to AMP unlocks γ and a Thr172 is 
phosphorylated by an upstream AMPK kinase, this activates the AMPK trimer complex 
(Hardie et al. 2005; Nagata and Hirata 2010).  
32  
 Hypoxia and ROS are potent activators of AMPK (Choi et al. 2001). In mammals, 
ATP depletion inhibits mTOR (Dennis et al. 2001) through activation of AMPK and 
subsequent phosphorylation of tuberous sclerosis complex (TSC1/2) (Inoki et al. 2003). 
The class I PtdIns3K/mTOR pathway is a negative regulator of autophagy in mammalian 
cells (Ravikumar et al. 2004). While Ha et al. (2010) demonstrated oxidative stress-
induced autophagic cell death in H9c2 cells was reversed by propofol, an antioxidant, 
treatment via inhibition of oxidative stress-dependent JNK and AMPK activation (Ha et 
al. 2010).  
  Activated AMPK also decreases protein synthesis and inhibits cell growth and 
hypertrophy (Inoki et al. 2003). In anoxic cardiac myocytes, however, activation of 
AMPK leads to an inhibition of protein synthesis through phosphorylation of eukaryotic 
elongation factor-2 (eEF2) rather than by the inhibition of mTOR (Horman et al. 2003). 
Since eEF2 kinase, which phosphorylates eEF2, regulates autophagy (Wu et al. 2006) 
ischemia-induced autophagy may be mediated through the AMPK-eEF2 kinase pathway 
rather than through the AMPK-induced inhibition of mTOR. AMPK may also stabilize 
p27 (cyclin-dependent kinase) through phosphorylation, which in turn mediates 
autophagy (Liang et al. 2007). Since the AMPK α2 subunit contains a putative nuclear 
localization signal (Arad et al. 2007) it is possible that AMPK has direct effects upon the 
transcription of genes involved in autophagy (Takagi et al. 2007). 
  Under conditions of stress, such as excessive load or ischemia, AMPK activates the 
glycolytic pathway by phosphorylating and activating phosphofructokinase-2 (Marsin et 
al. 2000) and enhancing fatty acid β-oxidation (Kudo et al. 1995). Furthermore, it 
promotes the translocation of GLUT-4 to the plasma membrane and increases the uptake 
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of glucose to the skeletal muscle to ameliorate relative ATP deficiencies (Russell et al. 
1999). Diabetes remedies, such as metformin or thiazolidine derivates, can activate 
AMPK (Fryer et al. 2002), suggesting the possibility that AMPK can become a 
therapeutic target of metabolic abnormalities. 
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Objectives 
 
  There have been no studies to date investigating the cumulative effects of 
hyperglycemia and hypoxia on cardiac oxidative stress. The role of apoptosis and 
autophagy in conditions of simultaneous hyperglycemia and hypoxia in cardiac H9c2 
cells is still unclear. This study aims to better understand the mechanism(s) of oxidative 
stress-induced cardiac damage in a hyperglycemia and hypoxia model, multiple markers 
of oxidative stress, apoptosis and autophagy were investigated. 
 
Hypothesis 
In this study we hypothesize that increased oxidative stress in high glucose and/or 
hypoxia conditions will correlate with increased apoptosis and a decrease in autophagy 
and cell viability.  
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Methods 
 
1.1 H9c2 ventricular cardiomyocyte cell line 
Rat cardiac ventricular cells (H9c2) were obtained from the American Type 
Culture Collection (Manassas, VA) and grown in Low Glucose Dulbecco’s Modified 
Eagle’s Medium (DMEM) (Hyclone, Logan, Utah), supplemented with 10% fetal bovine 
serum albumin (Hyclone, Pittsburgh, PA) and 1% antibiotic-antimycotic (Gibco, 
Aukland, NZ). All H9c2 cells were cultured at 37°C, 5% CO2 and used for 
experimentation upon reaching approximately 80 to 90% confluence. This immortalized 
cell line has been shown to preserve several characteristics of the electrical and hormonal 
signaling pathways found in adult cardiomyocytes and hence make a useful model for 
studying various aspects of cell physiology and pathogenic physiology (Hescheler et al. 
1991). All experiments were completed with cultures between passage 60 and 72.  
 
1.2 Treatment conditions 
 High glucose treatments were made by adding the appropriate amounts of D-
glucose (Fisher, Fair Lawn, NJ) to serum- and antibiotic-free Low Glucose DMEM 
(Hyclone, Logan, Utah), followed by filter sterilization. The glucose concentration of the 
control treatment corresponds to a normal physiologic glucose condition and the glucose 
concentration of the high glucose treatment mimics the condition of diabetics in highly 
poor glycemic control (Sainio et al. 2010; Gao et al. 2007).   
The following lists the treatment conditions used: 
- Control group; H9c2 cells incubated in 5.6 mM D-glucose, serum- and antibiotic-free 
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DMEM, in normoxic (21% O2) conditions for 24h.  
- High glucose group; H9c2 cells incubated in 25 mM or 33 mM D-glucose (Fisher, 
Fair Lawn, NJ), serum- and antibiotic-free DMEM, in normoxic (21% O2) conditions 
for 24h.  
- Hypoxia group; H9c2 cells incubated in 5.6 mM D-glucose, serum- and antibiotic-free 
DMEM, in hypoxic conditions (O2/N2/CO2; 1:94:5) for 24h.  
- High glucose and hypoxia group; H9c2 cells incubated in 25 mM and 33 mM D-
glucose, serum- and antibiotic-free DMEM, in hypoxic conditions (O2/N2/CO2; 1:94:5) 
for 24h.  
 
1.3 Hypoxia treatment 
 The hypoxia, glove box, chamber was humidified, with built in O2 and CO2 sensors 
and an automatic controller (Coy, Grass Lake, MI, USA). This hypoxia chamber was 
used for all hypoxia treatments. The controllers were set to 37°C, 5% CO₂ and 1% O₂. A 
separate, interior, humidified tissue culture chamber acted as the incubator. This inner 
chamber was covered with aluminum foil to protect cells incubating in light sensitive 
media/reagents. All interior surfaces, including the shelves in the inner chamber, were 
routinely wiped and sterilized with ethanol. Cell cultures were carefully taken in/out of 
the hypoxia chamber via a purge-able airlock chamber. O₂ levels became negligible (very 
close to 0%) within the airlock chamber after a 115 second purge. This assured that O₂ 
levels did not fluctuate by more than 1% O₂, during the addition or removal of cell 
cultures from the chamber. 
 
37 
 
1.4 Cel viability assay 
 Cel  viability  was  measured  using a  quantitative colorimetric assay  with thiazolyl 
blue tetrazolium  bromide (MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide). MTT reagent is converted to purple formazan crystals in living cels, thereby 
showing the  mitochondrial activity. It is a light sensitive, in vitro assay for the 
measurement of cel proliferation or, when metabolic events lead to apoptosis or necrosis, 
a reduction in cel  viability. H9c2 cels (1 ×  10) were seeded  onto a sterile flat-
botomed, 96-wel tissue culture plate (Corning) and incubated overnight to achieve the 
desired confluence. Then  plated cels  were exposed to  normoxic (21%  O2)  or  hypoxic 
(1% O2) conditions at various D-glucose concentrations (5.6, 25, 33 mM) in serum- and 
antibiotic-free media. With t = 4h of treatment time remaining, MTT reagent (Sigma, St. 
Louis, MO, USA) was added to each wel to achieve a final MTT concentration of 10% 
(v/v), and cels  were incubated at  37°C for an additional  4h.  Folowing this, the  media 
was removed and the reaction  was terminated  by adding  50  µL  of  dimethylsulfoxide 
(DMSO) per wel and placed on a Bely Dancer shaker (Stoval, Greensboro, NC, USA) 
for  10  minutes (highest seting) to solubilize the formazan crystals.  Absorbance  was 
measured,  using a  PowerWave  XS  Microplate  Spectrophotometer (BioTek,  Winooski, 
VT, USA), at wavelengths 570 nm and 650 nm (corection wavelength).  
 
1.5 Measurement of intracelular reactive oxygen species (ROS) 
 The DCF assay measures the levels of intracelular ROS. Cels are incubated with 
the  CM-H2DCFDA (5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein  diacetate, 
acetyl ester) which can difuse through the cell membrane. This molecule remains non-
38  
fluorescent until the acetate groups are removed by intracellular esterases as oxidation 
occurs within the cell. In addition, esterase cleavage yields a charged form of the dye that 
is unable to leave the cell. Reaction with ROS, primarily H2O2, results in the fluorescent 
molecule DCF. This DCF fluorescence can be used as a measure for intracellular ROS 
levels. Cells were seeded onto sterile flat-bottom 25 cm² culture flasks (Corning) and 
grown overnight to achieve the desired confluence. Plated cells were subjected to 24h of 
normoxia (21% O2) or hypoxia (1% O2) at various D-glucose concentrations (5.6, 25, 33 
mM) in serum- and antibiotic-free media. Following treatment, cells were washed with 
phosphate buffered saline (PBS) and stained for 30 minutes with CM-H2DCFDA 
(Molecular Probes, Eugene) in normoxia. Stained cells were washed with PBS and 
detached from the plate surface using trypsin (Fisher Scientific) and suspended in PBS 
for flow cytometric analysis using the FL1-H channel of a BD FACSCalibur Flow 
Cytometer (BD Biosciences) supported by BD CellQuest Pro Software. A minimum of 1 
x 106 gated events were acquired per trial. Geometric mean fluorescence is directly 
proportional to the intracellular ROS levels.  
 
1.6 Active caspases 3/7-based apoptosis detection assay 
 Fluorochrome inhibitors of Caspase (FLICA), a cell-permeable, 
carboxyfluorescein-labeled fluoromethyl ketone peptide inhibitor, covalently binds to a 
reactive cysteine residues found on active caspases. This binding thereby inhibits further 
enzymatic activity of caspase. Bound labeled reagent is retained within the cell, while 
unbound reagent diffuses out of the cell and is washed away. The amount of active 
caspase-3 or 7, present in the cell at the time the reagent was added, is measured directly 
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by a  green fluorescent signal.  Control and treated cels  were stained  with  FLICA  using 
the  CaspaTag  Caspase-3/7 In  Situ  Assay  kit (Chemicon International,  Temecula,  CA). 
Active caspase-3/7 activity was assessed via flow cytometric analysis (BD Biosciences). 
Cels  were seeded  onto sterile flat-botom  25 cm² culture flasks (Corning) and  grown 
overnight to achieve the  desired confluence.  Plated cels  were subjected to  48h  of 
normoxia (21% O2) or hypoxia (1% O2) at various D-glucose concentrations (5.6, 25, 33 
mM) in serum- and antibiotic-free  media.  Folowing treatment, cels  were  washed  with 
1X  wash  bufer (provided),  detached from the  plate surface  using trypsin (Fisher 
Scientific) and suspended in  PBS to achieve  1  x 10 cels/mL.  10  µL  of reconstituted 
and aliquoted  FLICA reagent  was added to  300  µL  of cel suspension (0.1%  bovine 
serum albumin (BSA; Fisher) /PBS), mixed gently and incubated at 37°C, 21% O2, 5% 
CO2 for  1  hour in the  dark (flicking tubes  gently every  20  minutes  during this 
incubation).  Folowing two  washes and resuspension in  400  µL  of  1X  wash  bufer, 
samples  were immediately analyzed  via flow cytometry  with a  BD  FACSCalibur  Flow 
Cytometer (BD  Biosciences) supported  by  BD  CelQuest  Pro  Software  on the  FL1-H 
(FLICA) channel.  A  minimum  of  1  x  106 gated events  were acquired  per trial.  Cels 
without any  FLICA  were considered to  be living,  while cels containing  FLICA  were 
considered be to apoptotic. 
 
1.7 Protein Extraction 
 Cels  were seeded  onto sterile flat-botom  75 cm² culture flasks (Corning) and 
grown overnight to achieve the desired confluence. Plated cels were subjected to 24h of 
normoxia (21% O2) or hypoxia (1% O2) at various D-glucose concentrations (5.6, 25, 33 
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mM) in serum- and antibiotic-free media. Following treatment, cell samples trysinized, 
collected and centrifuged several times in PBS at 500g for 5 minutes at 4°C. The Nonidet 
P40 (NP-40) (Roche Diagnostics, Germany) buffer containing 150 mM NaCl, 1% NP-40, 
50 mM Tris (pH 8.0) and protease inhibitors phenylmethylsulfonyl fluoride, leupeptin, 
aprotinin and pepstatin was used to lyse cell samples for immunoblotting. Protease 
inhibitors were all prepared in advance and stored at -20°C. Inhibitors were added to the 
NP-40 buffer immediately prior to the buffers application and aliquots were refrozen. 
Once the ice-cold lysis buffer was applied to pelleted cell samples, the lysate was 
pipetted up and down repeatedly using a pipette tip. Lysates were gently vortexed, 
incubated on ice for 10 minutes and then centrifuged for 12 minutes at 1 x 104 rpm to 
remove cellular debris. Supernatant was collected and stored at -80°C and/or kept on ice 
for immediate quantitation.  
 Hypoxia treated cells were collected within the hypoxia chamber. Serum-free and 
antibiotic-free media, PBS and TryLE (trypsin) express (Gibco, Grand Island, NY) were 
deoxygenated in the hypoxia chamber prior to use. Lids of sample vials were tightened 
and covered with parafilm when samples were going to and from ambient O₂ during the 
extraction process. Samples were quickly placed on ice and stabilized with protease and 
phosphatase inhibitors in the NP-40 lysis buffer.  
 
1.8 Total protein quantification 
 A colorimetric, Lowry-based protein assay was used to quantitate protein lysates. 
Using a sterile flat-bottomed, 96-well tissue culture plate (Corning), the DC Protein 
Assay (Bio-Rad) was performed. This assay requires 5 µL of protein lysate, full-strength 
41  
samples to be measured alongside a range of BSA (Fisher) protein standard 
concentrations from 0.2-1.5 mg/mL. Following a 15 minute incubation period in room 
temperature, standard and sample absorbance was measured, using a PowerWave XS 
Microplate Spectrophotometer (BioTek), at a wavelength of 750 nm. Excel for Macintosh 
was used to create a standard curve from the BSA standards, and the equation of the line 
of best fit was used to calculate the sample protein concentrations. To minimize 
degradation of stock sample lysates, they were kept on ice the whole time. 
 
1.9 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
 Once sample lysates were quantified, 6x Laemmli sample loading buffer containing 
ß- mercaptoethanol (Sigma-Aldrich) was added to the sample lysates, which were then 
placed in a 97°C hot plate for 5 minutes. Boiled lysates were then cooled on ice, spun 
down for 30 seconds at 1 x 104 rpm and loaded into 8%, 10% or 15% SDS-PAGs at 25 or 
30 µg per well (Bio-Rad Mini PROTEAN 3 Cell System apparatus). Approximately 10 
µL (equivalent to 10 µg) of Spectra Multicolor High Range Protein Ladder (Thermo 
Scientific) or Precision Plus Kaleidoscope (Bio-Rad) protein standard was loaded 
alongside the sample wells. The electrophoresis apparatus was filled with 1x Running 
buffer (standard Laemmli 10x Running buffer diluted by 1:10 in double distilled water 
(ddH2O)). Gels were run at 80V until the sample front cleared the stacking gel (for about 
30 minutes), followed by 100V until the appropriate kDa range had migrated through the 
resolving gel. 
 
2.0 Electrophoretic transfer 
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 To prevent protein band dissociation, gels were removed from the electrophoresis 
assembly immediately upon completion of SDS-PAGE. Gels were trimmed at the edges, 
orientation marks added, then soaked in 1x Transfer buffer for 10 minutes for 
equilibration (standard Laemmli 10x Transfer buffer diluted by 1:2:7 in 70% methanol 
(Fisher) and ddH₂O). Polyvinylidene fluoride transfer membrane (PVDF, Pierce, 
Rockford, IL, USA) was soaked in methanol for 15 minutes. The transfer cassette was 
assembled as per the manufacturer’s instructions and filled with 1x Transfer buffer. The 
transfer was performed at 100V for 2h, with ddH2O ice block, while in a box of crushed 
ice.  
 
2.1 Immunoblotting  
 Once electrophoretic transfer was completed, gels were soaked in Coomassie Blue 
dye (Sigma) on the Belly Dancer Shaker (Stovall, Greensboro, NC, USA) for at least 1h 
and then soaked in de-stain (70% ethanol and ddH2O) solution to verify successful 
protein gel migration and transfer (bands observed are of proteins not transferred). 
Membranes were stained with Ponceau S solution (Bio-Rad) for 10 minutes to further 
verify transfer efficiency. To remove Ponceau S stain, the membrane was immersed in 
0.1M sodium hydroxide for 30 seconds followed by successive washes in ddH2O. The 
membranes were then soaked in 1x Tris-buffered saline containing 0.1% Tween-20 
detergent (TBST) (Sigma) three times, 5 minutes each time (protein side up) to wash and 
equilibrate them before being blocked with 5% dehydrated milk powder in TBST 
solution overnight (~16h) at 4°C.  
 Blocked membranes were rinsed in TBST three times, 10 minutes each time, before 
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incubation with primary antibodies. Antibodies were diluted by 1:100-1:1000 in 5% BSA 
and TBST and stored at 4°C. The primary antibodies used were: β-actin (loading control), 
Bax, Bcl-2 (Santa Cruz Biothechnology, Santa Cruz, CA), caspase 3, AMPKα, Phospho-
AMPKα (Thr172, P-AMPKα) and LC3B-II (Cell Signaling Technology, New England). 
Membranes were then washed in TBST three times for 10 minutes. Following this step, 
1:100-1:1000 horseradish peroxidase (HRP)-conjugated goat anti-rabbit or goat anti-
mouse (Pierce and R&D Systems) IgG secondary antibodies in 5% BSA solution were 
used to probe the membrane on a shaker for 2h at room temperature or overnight (~16h) 
at 4°C. Following this step, membranes were again washed with TBST three times for 10 
minutes. Following enhanced chemiluminescent (ECL) imaging, a ‘medium’ strength 
stripping buffer, containing SDS, was used to sufficiently remove antibodies from the 
membranes for immediate re-blotting. 
 
2.2 Enhanced chemiluminescence and densitometry 
 The method of ECL utilizes HRP enzyme tethered to a molecule of interest through 
a labelled immunoglobulin that specifically recognizes that molecule. The ECL substrate 
is converted into a sensitized compound, H2O2 oxidizes this to emit light upon decay. The 
HRP enzyme complex catalyzes this reaction. Standard ECL was performed to detect 
protein bands on the immunoblots via 10 minute High-Sensitivity Chemiluminescent 
exposures using a Chemidoc XRS imager (Bio-Rad) supported by Quantity One software 
for Windows (Bio-Rad). Epi-White exposures were also collected and membranes were 
scanned in order to decipher banding patterns and protein ladders. Blots were later 
analyzed via densitometry using the Quanity One software, with target protein densities 
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normalized to the β-actin loading control. 
 
2.3 Statistics 
 The data is presented as mean ± standard error of the mean (SEM). An n ≥ 3 
independent experiments was obtained for all read outs. GraphPad Prism software was 
used for statistical analyses. One-way ANOVA with Tukey’s multiple comparison test 
were utilized, with p < 0.05 considered as significant. Asterisks are used herein to denote 
significance according to the following scheme: * = p < 0.05; ** = p < 0.01; *** = p < 
0.001. 
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Results 
 
1.1 Effect of high glucose and hypoxia on cell viability  
 Cell viability was assessed via the colourimetric MTT assay. H9c2 cells were 
subjected to various concentrations of D-glucose treatment (5.6, 25 and 33 mM D-
glucose) for 12h, 24h, 48h (data not shown) and 96h at 37°C, 5% CO2. Cell viability was 
significantly reduced by 33 mM D-glucose in normoxic after 96h (25 ± 5.8%, p < 0.01) 
when compared to the control (Figure 1). Cells treated for 24h with 25 mM (14.49 ± 
2.7%, p < 0.01) and 33 mM D-glucose (25.8 ± 2.9%, p < 0.001) under hypoxic conditions 
showed significantly decreased cell viabilities when compared to control (Figure 2).  
 
1.2 Effect of high glucose and hypoxia on oxidative stress in H9c2 cardiomyocytes 
 High glucose and hypoxia-induced oxidative stress was investigated in cultured 
H9c2 cells. Intracellular ROS levels were assessed using the CM-H2DCFDA assay and 
measured via flow cytometry. A 48h treatment with increasing D-glucose concentrations, 
in normoxia, did not cause significant increases in ROS generation (Figure 3). However 
cells exposed to 25 mM D-glucose for 48h in hypoxia caused a significant increase (44 ± 
6.6, p < 0.001)  in ROS generation when compared to all the other treatments, including 
the control (in normoxia: control, 10.6 ± 2.1, p < 0.001; 25 mM, 18.2 ± 4.3, p < 0.01; 33 
mM, 19 ± 2.9, p < 0.01 and in hypoxia: 5.6 mM, 23.2 ± 2.3, p < 0.05; 33 mM, 23.1 ± 2.9, 
p < 0.05). There is a slight but non-significant increase in ROS generation in the hypoxia 
treatments versus the normoxia treatments. These data indicate a pronounced elaboration 
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of ROS resulting from the simultaneous treatment of 25 mM D-glucose and hypoxia in 
H9c2 cells. The non-significant differences in ROS generation between the 5.6 mM and 
33 mM D-glucose treatments in hypoxia indicate a biphasic trend (Figure 3). 
 
1.3 Effect of high glucose and hypoxia on active caspase 3 and 7 activity in H9c2 
cardiomyocytes 
 To determine whether high glucose and hypoxia-induced ROS generation resulted 
in cell death via apoptotic mechanisms, the activity of apoptotic enzymes, caspases 3 and 
7, via the CaspaTag caspase 3/7 In Situ Assay kit and flow cytometry were examined. 
High glucose, in normoxia for 24h, caused a non-significant decrease in caspase 3 and 7 
activity. In hypoxia, high glucose induced increased levels of caspase 3 and 7 activity, of 
which the 25 mM D-glucose treatment was significant. Cells exposed to 24h of 
simultaneous 25 mM D-glucose and hypoxia resulted in significantly increased caspase 3 
and 7 activity (29.4 ± 4.9, p < 0.001) when compared to all other treatments including the 
control (in normoxia: control, 12.7 ± 2.2, p < 0.001; 25 mM, 11.8 ± 1.7, p < 0.001; 33 
mM, 10.4 ± 1.5, p < 0.001 and in hypoxia: 5.6 mM, 18.7 ± 1.0, p < 0.05; 33 mM, 16.7 ± 
1.2, p < 0.01). These findings suggest that simultaneous treatment of high glucose and 
hypoxia induce activation of apoptotic effector caspases. Treatment with simultaneous 33 
mM D-glucose and hypoxia resulted in a decrease in apoptosis (Figure 4).  
 
1.4 Effect of high glucose and hypoxia on caspase 3, Bax and Bcl-2 protein 
expression 
Given the increased ROS generation (Figure 3) and increased caspase 3 and 7 
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activity (Figure 4) due to simultaneous treatment with high glucose and hypoxia, we 
decided to further investigate high glucose and hypoxia-induced apoptosis by assessing 
caspase 3, Bax, and Bcl-2 protein expression via immunoblotting. Caspase 3 protein 
expression, displayed as a ratio of cleaved (active)/non-cleaved (inactive) caspase 3, did 
not change significantly after 24h of high glucose and/or hypoxia treatment when 
compared to control, but a trend, of increasing protein expression with high glucose 
and/or hypoxia, was observed (Figure 5). Bax protein expression was significantly 
increased after 24h of 25 mM D-glucose in hypoxia (1.5 ± 0.1 fold, p < 0.05) when 
compared to control (Figure 6). Bcl-2 protein expression did not change significantly 
after 24h of high glucose and/or hypoxia, when compared to control. However, Bcl-2 
protein expression was observed to gradually decrease with increased D-glucose 
concentrations and/or hypoxia (Figure 7). These findings further indicate simultaneous 
high glucose and hypoxia-induced apoptotic cell death. 
 
1.5 Effect of high glucose and hypoxia on LC3B-II protein expression in H9c2 
cardiomyocytes 
 Protein expression of the autophagy marker, LC3B-II was assessed via 
immunoblotting. LC3B-II protein expression, shown as a ratio of LC3B-II/LC3B-I 
protein expression, did not change significantly after 24h of high glucose and/or hypoxia, 
when compared to control. However, LC3B-II/LC3B-I protein expression was observed 
to gradually decrease with increased D-glucose concentrations and/or hypoxia (Figure 
8). These results suggest that high glucose treatment diminishes autophagy levels and this 
effect is exacerbated by hypoxia treatment.  
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1.6 Effect of high glucose and hypoxia on AMPKα and P-AMPKα (Thr172) protein 
expression 
Hypoxia and ROS have been known as potent activators of AMPK, a central 
modulator in metabolic regulation and autophagy (Choi et al. 2001). Phosphorylation of 
the Thr172 residue, in the kinase domain of AMPKα, activates kinase activity (Hardie et 
al., 2005). AMPKα and P-AMPKα protein expression was assessed via immunoblotting 
and protein expression of both were not significantly altered after 24h of high glucose 
and/or hypoxia treatment, when compared to control levels (Figure 9 and 10). P-
AMPKα protein expression showed a gradual decrease with increased D-glucose 
concentrations, followed by a biphasic response to glucose and hypoxia. P-AMPKα 
protein expression increased in response to 24h of 5 mM and 33 mM D-glucose and 
hypoxia but was decreased in response to 25 mM D-glucose and hypoxia (Figure 9 and 
10). This finding suggests that AMPKα protein regulation could be post-translational 
under high glucose and/or hypoxia conditions. These results also suggest that high 
glucose can lead to a decrease in P-AMPKα and cell survival, and this decrease is 
reversed after exposure to simultaneous glucose and hypoxia.  
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Figure 1. Effect of glucose levels on cell viability. H9c2 cells were treated with serum-
free medium containing 5.6 mM (control, 5.6 H-G+), 25 mM and 33 mM D-glucose, in 
normoxia (21% O2), 96h (H-G+ indicates normoxia and D-glucose). Cell viability was 
assessed by the MTT assay.  Bars represent mean ± SEM of 3 independent experiments. 
Data is expressed as mean absorbance (** = p < 0.01 versus control; # = p < 0.05 versus 
25 mM D-glucose). 
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Figure 2. The cumulative effect of high glucose levels and hypoxia on cell viability. 
Cells were treated with serum-free medium containing 5.6 mM, 25 mM and 33 mM D-
glucose, in hypoxia (1% O2), 96h (H+G+ indicates hypoxia and D-glucose). Bars 
represent mean ± SEM of 3 independent experiments. Data is expressed as mean 
absorbance (*** = p < 0.001 versus control; ** = p < 0.01 versus control; # = p < 0.05 
versus 25 mM D-glucose and hypoxia). 
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Figure 3. Effect of high glucose and/or hypoxia on oxidative stress in H9c2 
cardiomyocytes. The effect of high glucose and/or hypoxia (1% O2) on intracellular 
ROS levels in H9c2 cells was assessed via fluorescent detection of oxidation-induced 
esterase activity (CM-H2DCFDA assay), and analyzed via flow cytometry. Cells were 
treated in medium containing 5.6 (control, H-G+), 25 and 33 mM D-glucose and/or 
hypoxia (1% O2) (H-G+ indicates normoxia and D-glucose; H+G+ indicates hypoxia and 
D-glucose). Bars represent mean ± SEM of at least 3 independent experiments. Data is 
expressed as mean fluorescence arbitrary units (a.u.) (* = p < 0.05; ** = p < 0.01, ***= p 
< 0.001). 
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Figure 4. Effect of high glucose and/or hypoxia on apoptosis in H9c2 
cardiomyocytes. The effect of high glucose and hypoxia on H9c2 cellular apoptosis 
(activity of apoptotic enzymes, caspases 3 and 7) was assessed using the CaspaTag 
caspase 3/7 In Situ Assay kit and measured via flow cytometry. Cells were treated in 
serum-free media containing 5.6 (control, H-G+), 25 and 33 mM D-glucose and/or 
hypoxia (1% O2) (H-G+ indicates normoxia and D-glucose; H+G+ indicates hypoxia and 
D-glucose). Bars represent mean ± SEM of 3 independent experiments. Data is expressed 
as mean fluorescence arbitrary units (a.u.) (* = p < 0.05; ** = p < 0.01, ***= p < 0.001). 
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Discussion 
 
1.1 High glucose and/or hypoxia reduce cell viability and induce oxidative stress in 
H9c2 cardiomyocytes 
 Exposure of cardiomyocytes to high glucose decreased cell viability (Figure 1), a 
treatment effect exacerbated in the presence of hypoxia (Figure 2). In support of our 
results in high glucose and normoxia, Younce et al. (2010) exposed H9c2 
cardiomyoblasts to high glucose (28 mM D-glucose, 24h) and found cell death was 
induced in a concentration- and time-dependent manner (Younce et al. 2010). Yu et al. 
(2010) used intracellular calcein fluorescence to demonstrate a significant decrease in cell 
viability of H9c2 cells incubated in high glucose (25 mM D-glucose, control; 5 mM), 
after 96h. H9c2 cells were shown to exhibit significant concentration- and time-
dependent DNA fragmentation and cell loss (Yu et al. 2010). In another experiment, Cai 
et al. (2002) showed that incubation on H9c2 cells with high D-glucose (22, 33 and 60 
mM, control; 5.5 mM) concentrations resulted in significant decreases in cell viability.  In 
their study, significant decreases in cell viability with 33 mM D-glucose were not 
observed until 96hof exposure (Cai et al. 2002). Cultured VSMCs grown in high glucose 
media concentrations were found to increase their proliferative rate when compared to 
their normoglycemic control (Ruiz et al. 2006). Enhanced VSMC proliferation has also 
been demonstrated in both human and experimental models of diabetes (Reddy et al. 
2006; Rizzoni and Rosei 2006).  The lack of proliferation and the decreased cell viability 
in H9c2 cells exposed to high glucose treatments suggests that cell survival and growth 
may be suppressed by the promotion of PCD.  
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 The results of our study showed that high glucose treatment promotes cell death 
and this is exacerbated in conditions of simultaneous high glucose and hypoxia (Figure 
2).  Gao et al. (2007) used bovine aortic smooth muscle cells (BASMC) to examine the 
effects of high glucose (25 mM D-glucose and 5.5 mM control, 5 days) on BASMC 
growth (proliferation and apoptosis) under normoxic (5% CO2, 95% air) and chronic 
hypoxic (2% O2, 5% CO2, 93% N2) conditions and reported that simultaneous high 
glucose and hypoxia treatment significantly increased the rate of BASMC proliferation. 
Hypoxia alone decreased cell proliferation when compared to normoxia, in which the 
proliferative state of these cells did not change (Gao et al. 2007).  
 Increased ROS production is observed in type 1 and type 2 diabetes and is 
considered to be a major contributing factor in the development of diabetic 
cardiomyopathy (Desco et al. 2002; San Martin et al. 2007). A 75 gram glucose challenge 
in vivo has been shown to induce increased O2•¯ generation by leukocytes and subunits 
of NADPH oxidase, the enzyme that converts molecular O2 to O2•¯ radical (Mohanty et 
al. 2000). Cai et al. (2002) also showed significant high glucose (33 mM)-induced ROS 
formation in cardiac H9c2 myocytes (Cai et al., 2002). In addition, Younce et al. (2010i) 
demonstrated high glucose (28 mM D-glucose, 24h)-induced MCP-1 production, in H9c2 
cardiomyoblasts and NRVM. MCP-1 was observed to induce MCPIP, which mediates 
high glucose-induced cell death via its induction of ROS. It was revealed that MCPIP 
mediates glucose-induced NADPH oxidase activation, a major source of ROS (Younce et 
al. 2010i). However, our results showed that exposure of cells to high glucose 
concentrations did not stimulate the production of ROS (Figure 3). We observed a slight, 
but non significant, increase in ROS generation at high glucose levels.  
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Nonetheless, in our study, the generation of ROS was significantly increased in 
conditions of simultaneous 25 mM D-glucose and hypoxia treatment (Figure 3). This is 
supported by Mrianda et al. (2011), who also investigated, in vitro, high glucose (25 mM 
D-glucose and 5 mM D-glucose control, t=18 days, at 37°C, 5% CO2) and/or hypoxia (at 
(t-6h) for control and (t-24h) for high glucose group, 1% O2) using ARPE-19 cells, a 
spontaneously immortalized human retinal pigment epithelium cell line. In addition to 
increased ROS generation, their study observed that simultaneous high glucose and 
hypoxia treatment also upregulates CHOP expression, triggers activation of JNK and p38 
mitogen-activated protein kinase (MAPK), reflective of ER stress, and provokes the 
disruption of tight junctions in ARPE-19 cells (Miranda et al. 2011). Ornoy et al. (2010) 
found that 5 and 7 mg glucose/ml (27.8 mM and 38.9 mM glucose, respectively) culture 
medium produces embryonic damage and enhanced oxidative stress as well as increased 
HIF 1a in 10.5-day-old rat embryos and their yolk sacs, thus pointing to the possibility 
that hyperglycemia may also cause hypoxia (Ornoy et al. 2010). Ornoy et al. (2011) 
demonstrates that both hypoxia (10% O2, 24h, followed by 20% O2 , 4h) and high glucose 
(556mg/dl or 30.89 mM D-glucose, 28h) and their combination, produce embryonic 
damage in 10.5-day-old cultured rat embryos probably by increasing embryonic oxidative 
stress (Ornoy et al. 2011). In pregnant mice hyperglycemia was found to induce oxidative 
stress, reduce pax-3 gene expression, a gene necessary for the closure of the neural tube, 
thus causing an increased rate of neural tube defects (Chang et al. 2003). Li et al. (2005) 
then showed that hypoxia intensifies the effects of hyperglycemia by further decreasing 
the activity of Pax 3 gene in mouse embryos, whereas hyperoxia reduced these damaging 
effects (Li et al. 2005). In these studies the antioxidant vitamin E succinate was found to 
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block both the effects of hypoxia and of hyperglycemia (Li et al. 2005). Thus, a clear 
connection between hyperglycemia and hypoxia, both inducing oxidative stress, appears. 
However, our results show a biphasic trend, in which simultaneous 33 mM D-glucose 
and hypoxia decreased ROS production, down to control levels (Figure 3). In light of the 
studies mentioned, our results suggest that H9c2 cardiomyocytes are prone to oxidative 
stress due to high glucose (25 mM D-glucose) and hypoxia-induced increases in ROS 
production. We need to further investigate why H9c2 cardiomyocytes respond in a 
biphasic fashion when exposed to an even higher D-glucose (33 mM) concentration, in 
hypoxic conditions.   
 
1.2 High glucose and/or hypoxia-induced apoptotic cell death in H9c2 
cardiomyocytes 
  Apoptosis is a form of caspase-dependent PCD. Caspases, cytosolic cysteine 
endopeptidases, are activated either following stimulation of death receptors on the 
plasma membrane (extrinsic pathway), such as tumour necrosis factor receptor 1 
(TNFR1), or the intrinsic mitochondrial pathway. Both pathways involve the cleavage 
and activation of executioner caspases 3 and 7. The morphological characteristics of 
PCD-1 include chromatin condensation and fragmentation of nucleus and cytoplasm into 
apoptotic bodies (Edinger and Thompson 2004; Green and Kroemer 2004). Apoptosis is 
increased in STZ-induced diabetic mice myocardium and H9c2 cardiomyocytes exposed 
to high levels of glucose. High glucose exposure has been demonstrated to directly cause 
apoptosis in H9c2 cells (Cai et al. 2002). Mitochondrial cytochrome c release is a key 
event in the activation of caspase-3 and 7 (Roy 2000). Mitochondrial cytochrome c 
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release and caspase-3 activation have been found to be associated with hyperglycemia-
induced myocardial apoptosis, in vivo and in vitro. There is a positive correlation 
between ROS production and mitochondrial cytochrome c release–mediated caspase-3 
activation, in H9c2 cells. Stress-induced ROS production has been suggested to play, at 
least in part, a critical triggering role in the mitochondrial cytochrome c–mediated 
caspase-3 activation pathway of apoptotic cell death (Cai et al. 2002).  
  Hypoxia induces caspase-dependent (apoptosis) and caspase-independent PCD 
(necrosis) (Shimizu et al. 1996). During cell death by hypoxia, death effectors are 
released from the intermembrane spaces of mitochondria and into the cytoplasm where 
they proceed to initiate apoptotic and necrotic pathways (Wang 2001i; Gustafsson et al. 
2008). Oxidative stress, hypoxia and hyperglycemia can disturb ER function and 
compromise the adaptive UPR, resulting in persistent ER stress. This leads to sustained 
activation of CHOP (proapoptotic transcription factor) and JNK (stress kinase). Both 
JNK and CHOP attenuate the function of the pro-survival factor Bcl-2, but enhances the 
activity of pro-apoptotic Bcl-2 proteins such as Bim, Bax, and PUMA, resulting in 
mitochondrial dysfunction and cytochrome c release. In addition, caspase-12 is activated 
during ER stress, which sequentially activates caspase-7 and/or caspase-3, leading to 
mitochondria-independent apoptosis (Jing et al. 2012). Both mitochondrial-dependent 
and independent apoptotic pathways may be triggered in the 25 mM D-glucose and 
hypoxia treatment. This may explain the significant increase in activated caspase 3/7 in 
high glucose (25 mM D-glucose) and hypoxia treated cells compared to treatment with 
33 mM D-glucose and hypoxia, which did not alter the levels of activated caspase 3/7 
levels. 
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  Aki et al. (2010) have demonstrated that glucose uptake and glycolysis rescues 
H9c2 cells from ATP depletion and subsequent caspase-independent (necrosis) death, 
during hypoxia. However, their results suggested these protective effects of glucose are 
limited to concentrations at which cells can assimilate them. In partial support of our 
results, Aki et al. (2010) discovered a bifurcate property of glucose and proposed that 
different types of cell death are induced by hypoxia depending on extracellular glucose 
concentrations. According to their study, glucose concentrations of 2.78–16.7 mM were 
found to protect H9c2 cells from hypoxic death in a dose-dependent manner, in contrast 
to high concentrations of glucose, 19.7–25 mM, which promote hypoxia-induced 
apoptotic cell death (Aki et al. 2010). We observed increased apoptosis in H9c2 cells 
exposed to a 24h co-treatment of 25 mM D-glucose and hypoxia. However, Malliopoulou 
et al. (2006) observed acute high glucose pretreatment (22 mM, 15 minutes) to reduce 
cell death and protect H9c2 cells from hypoxic injury (serum-, glucose- and O₂-free). 
High glucose exposed-H9c2 cells displayed increased intracellular glucose concentrations 
and glucose is shown to exert its early protective effect against hypoxic insult, as an 
energy providing substrate in glucose metabolism (Malliopoulou et al. 2006). Pastukh et 
al. (2005) also described a similar phenomenon of protection using NRVM exposed for 3 
days in high glucose (25 mM) media. Their high glucose treatment reduced apoptosis and 
necrosis induced by chemical hypoxia (Pastukh et al. 2005). Our results suggest that a 
combination of 25 mM D-glucose and hypoxia promotes apoptotic cell death, whereas 33 
mM D-glucose and hypoxia conditions attenuate this pro-apoptotic signal. Considering 
the concentration dependent decreases in cell viability, in glucose and hypoxia conditions 
(Figure 2), it is worth investigating other cell death-inducing pathways such as 
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autophagy and necrosis.  
  To further investigate this biphasic trend and simultaneous high glucose and 
hypoxia-induced apoptosis, caspase 3, Bax, and Bcl-2 protein expression was assessed 
via immunoblotting. Both caspase 3 and Bax protein expression show a trend of 
increasing protein expression with simultaneous high glucose and hypoxia compared to 
normoxic conditions (Figure 5 and 6). However, only Bax showed a significant increase 
in protein expression when cells were exposed to simultaneous high glucose and hypoxia, 
compared to the control. Bcl-2 protein expression did not change significantly but its 
protein expression was observed to gradually decrease with increased D-glucose 
concentrations and/or hypoxia (Figure 7).  
  In contrast to our findings, hyperglycemia, alongside hypoxia, has been 
demonstrated to inhibit HIF-1α expression, inhibit hypoxia-induced decreased 
proliferation of VSMCs and a concomitant decrease in HRE promoter transactivation 
(Gao et al. 2007). In a rat model of cerebral ischemia both mRNA and protein expression 
of HIF-1α and procaspase 3 increased after 12h and 24h of ischemic insult, there was also 
an increase in specific HIF-1 binding to the caspase 3 gene promoter (Van Hoecke et al. 
2007). Since hypoxia leads to increased mitochondrial ROS generation (Mansfield et al. 
2005), it is enough of an increase to activate HIF-1α (Chandel et al. 2000). It is also 
suggested that HIF-1α promotes apoptosis by activating the pro-apoptotic Bcl-2 family 
protein Bax. The HIF-1 complex is suggested to be necessary for hypoxia-induced Bax 
expression (Ozawa et al. 2005). The complex also stabilizes p53 (An et al. 1998), which 
can then induce Bax translocation and thus initiate the mitochondrial cell death pathway 
(Ding et al. 2007).  
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 The pro-apoptotic Bcl-2 proteins have been widely implicated in cardiovascular 
disease. In the myocardial cells, Bax is activated in response to oxidative stress 
(Gustafsson et al. 2004) and simulated I/R (Kubli et al. 2007; Capano and Crompton, 
2006; Hamacher-Brady et al. 2006). Moreover, hearts of Bax deficient mice have reduced 
mitochondrial damage and infarcts size compared to wild type mice, suggesting that Bax 
is an important contributor to I/R injury (Hochhauser et al. 2003). The relative level of 
the pro- and anti- apoptotic Bcl-2 proteins determines whether a cell will survive or die 
following an apoptotic stimulus (Latif et al. 2000). Given the increase in caspase 3 and 7 
activity, the increased protein of caspase 3 and pro-apoptotic Bax and decreased protein 
expression of anti-apoptotic Bcl-2 protein expression, these data indicate simultaneous 
high glucose and hypoxia-induced oxidative results in increased apoptosis.  
 
1.3 High glucose and/or hypoxia-induced autophagy in H9c2 cardiomyocytes.  
 Nutrient depletion (Lum et al. 2005) and acute ischemia (Takagi et al. 2007) both 
induce autophagy to maintain mitochondria and ER function and promote cell survival. 
However, certain conditions, such as reperfusion (Takagi et al. 2007), high glucose 
exposure (Younce et al. 2010) and prolonged ER stress (Takemura et al. 2006, Younce et 
al. 2010), stimulate detrimental autophagy that promotes PCD. Autophagy depends on 
several key proteins including beclin-1 and LC3B (Takemura et al. 2006). Our results of 
the autophagy marker, LC3B-II, show a trend of gradually decreasing protein expression, 
with increased D-glucose concentrations and/or hypoxia (Figure 8). High glucose 
treatment is observed to diminish autophagy levels (Figure 8) while stimulating pro-
apoptotic protein (caspase 3, 7 and Bax) expression (Figure 5 and 6) and diminishing 
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anti-apoptotic Bcl-2 protein expression (Figure 7) in high glucose and/or hypoxia 
conditions.  
 It has been reported that high glucose (28 mM D-glucose) exposure of H9c2 
cardiomyoblasts and cardiomyocytes has been observed to induce oxidative stress and 
ER stress which eventually leads to increased autophagy (increased beclin-1 and LC3-II 
(LC3-I-PE) expression) and cell death (Younce et al. 2010). ER stress induces autophagy 
that is associated with cardiomyocyte death involved in heart failure (Takemura et al. 
2006). Younce et al. (2010i) provide a molecular explanation into how hyperglycemia 
can result in cardiomyocyte cell death that contributes to the pathophysiological 
progression of diabetic cardiomyopathy (Younce et al. 2010i). Intriguingly, ROS-induced 
autophagic cell death occurs via a beclin-1 dependent pathway (De Meyer and Martinet 
2009). Increased ROS levels activate the ubiquitin-proteosome system (Breitschopf et al. 
2000), which degrade anti-apoptotic, beclin-1 binding and inhibiting (Pattingre et al. 
2005), Bcl-2. This allows for beclin-1 activation and autophagic cell death (De Meyer 
and Martinet 2009). 
 Mitochondrial damage and/or failure of mitochondria to make enough ATP levels 
(such as during cell starvation) also leads to increased autophagic cell death (Gozuacik 
and Kimchi 2004; Levine and Yuan 2005). However we observed autophagy levels to 
decrease with increased D-glucose exposure, in normoxia (Figure 8). In normoxic and 
hypoxic conditions, we observed the decreases in autophagy to coincide with the 
decreases in H9c2 cell viability. This finding suggests that the autophagy may be 
beneficial/protective and that high glucose levels in hypoxia prevented the beneficial 
effects of autophagy in H9c2 cells.  
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 In response to high glucose and hypoxia, Miranda et al. (2011), observed the 
induction of ER stress and UPR (Miranda et al. 2011), using ARPE19 cells. Autophagy is 
deregulated in chronic obesity-related ER stress (Yang et al. 2010). Interestingly, their 
study demonstrated that at 24h of high glucose and hypoxia, a decrease in autophagy was 
evident due to a decrease in LC3B-II content, indicating defective autophagosome 
formation. This coincided with an up-regulation of caspase 3 and a down-regulation of 
anti-apoptotic Bcl-xL. Miranda et al. (2011) concluded that apoptosis might be a delayed 
response triggered when autophagy-mediated protection is impaired (Miranda et al. 
2011). We also observed a gradual decrease in the protein expressions of anti-apoptotic 
Bcl-2 and the autophagy marker (Figure 7 and 8). This also coincided with the increased 
protein expression of caspase 3 and pro-apoptotic Bax (Figure 5 and 6). Our results 
hence suggest the possible impairment of protective autophagy and the induction of 
apoptotic cell death in H9c2 cardiomyocyte exposed to high glucose and/or hypoxia.  
 
1.4 High glucose and/or hypoxia-induced P-AMPK protein expression 
 
  The AMPK protein is the inactive form of the protein, no particular trend in the 
protein expression of inactive AMPK was observed in our study (Figure 9), suggesting 
that modification of AMPK activity is post-translational. Once it is in an 
activated/phosphorylated form (P-AMPK), it has the ability to function as an “energy 
sensor” to respond to increased intracellular AMP concentrations (and decreased ATP) 
during hypoxia (Abbud et al. 2000). This accounts for the increased P-AMPK protein 
expression in simultaneous 5.6 mM and 33 mM D-glucose and hypoxia. Despite the 
presence of 33 mM D-glucose containing media during hypoxia, P-AMPK protein 
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expression was still induced but still less than the control (5.6 mM normoxia) (Figure 
10). Under hypoxic conditions, Jing et al. (2008) found that AMPK phosphorylation and 
activation is followed by the selective stimulation of the ERK1/2 pathway in H9c2 cells. 
The stimulation of this pathway is essential in the GLUT1 glucose transport response 
(Jing et al. 2008) of P-AMPK, in which it stimulates glucose transport into the 
mammalian cell to maintain ATP production (Fryer et al. 2002; Abbud et al. 2000). This 
serine-threonine kinase, AMPK, is inactive in ATP sufficient environments (Abbud et 
al.2000), hence the D-glucose concentration dependent decrease in P-AMPK protein 
expression (Figure 8) observed in normoxia.  
 AMPK plays an essential role in mediating glucose deprivation- or ischemia-
induced autophagy in primary NRVM, this is accompanied by the inhibition of mTOR 
and the subsequent stimulation of autophagy in the mouse heart in vivo (Matsui et al. 
2007, Takagi et al. 2007). The HIF-1 is upregulated in the heart under ischemic 
conditions (Kido et al. 2005) and HIF-1 is activated by AMPK (Lee et al. 2003). During 
myocardial ischemia (an energy starved state) a rapid drop in intracellular ATP leads to 
the activation of AMPK (Arad et al. 2007). The induction of autophagy by P-AMPK may 
contribute to the preservation of ATP content as well as promotion of cell survival 
(inhibits apoptotic cell death) in the ischemic heart. The activation of AMPK enhances 
ATP production through multiple mechanisms, including increases in glucose uptake, 
glycolysis, and fatty acid oxidation (Arad et al. 2007). The induction of autophagy allows 
for myocardial recovery from prolonged ischemia without significant myocardial injury 
(Decker and Wildenthal 1980). During ischemia, the ubiquitin proteasome pathway is 
generally inhibited in heart, (Powell 2006) so oxidized, misfolded and polyubiquitinated 
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protein aggregates accumulate. Autophagy is an alternative measure to scavenge and 
eliminate these aggregates in the heart during ischemia (Mizushima 2007). BNIP3-
induced autophagosomes often contain fragmented mitochondria in cardiac myocytes, 
(Hamacher-Brady et al. 2007) suggesting that autophagy removes damaged 
mitochondria. Taken together, our findings suggest that the model we have used in our 
study voids the ATP depletion caused by hypoxia. The lack or attenuation of ATP 
depletion by glucose may result in H9c2 treated cells to deviate away from this 
ischemia/AMPK/mTOR/cardio-protective autophagy pathway. Mitigation of cardio-
protective autophagy, needed to remove damaged mitochondria, triggers mitochondrial 
ROS-induced ROS release and generalized permeability transition pore opening, leading 
to the intrinsic pathway of apoptosis. 
 There is constitutive autophagic turnover of intracellular organelles such as 
mitochondria in highly oxidative tissues, including cardiac myocytes. Opening of the 
mitochondrial permeability transition and loss of mitochondrial membrane potential 
triggers their autophagic scavenging (Kim et al. 2007). Autophagic sequestration is also 
elicited by fission and subsequent depolarization of mitochondria (Twig et al. 2008). 
Thus, autophagy can protect from mitochondria that might otherwise trigger apoptotic 
cell death.  
  In mammals, P-AMPK is observed to inhibit mTOR (autophagy inhibitor) in 
ATP depleting conditions (Dennis et al. 2001) by phosphorylating and activating TSC1/2. 
P-AMPK is able to decrease protein synthesis and inhibit cell growth and hypertrophy. 
Despite the observed increases in P-AMPK, in 5.6 mM and 33 mM D-glucose and 
hypoxia (Figure 10), autophagy declined (Figure 8) during simultaneous glucose and 
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hypoxia treatment. Kanamori et al. (2011) demonstrated the induction of cardio-
protective autophagy in an in vivo model of myocardial infarction. The inhibition of 
autophagy, using Bafilomycin A1 (an autophagy inhibitor), resulted in elevated P-AMPK 
protein levels, while enhancing autophagy, with Rapamycin (an autophagy enhancer) 
treatment, reduced P-AMPK protein levels. This suggests Bafilomycin A1-mediated 
inhibition of autophagy interferes with the supply of ATP to the ischemic myocardium, 
leading to activation of AMPK, while Rapamycin-mediated activation of autophagy does 
the reverse (Kanamori et al. 2011). In light of this study, our results may indicate a defect 
or malfunction of the autophagy mechanism in 5 mM and 33 mM D-glucose and hypoxia 
treatments. Defective autophagosome or autophagolysosome formation could inhibit 
autophagy, reduce autophagic flux and the maintenance of ATP production in hypoxic 
conditions leading to elevated activation of AMPK proteins.  
 This finding is further supported by electron microscopy evidence from pancreases 
retrieved from diabetic human cadavers that present with a massive increase in 
overloaded autophagosomes. Decreased lysosome formation can lead to abnormal 
autophagosome morphology. Diabetic pancreatic β -cells have been shown to have 
significantly reduced levels of various lysosomal genes, including cathepsins B and D, 
and of lysosome-associated membrane proteins (Lamp)-2, which are respectively 
involved in protein degradation and in fusion with the autophagosomes. Pancreatic islets 
exposed to high fatty acid concentrations for 24h present with impaired autophagosome 
morphology and decreased Lamp-2 gene expression (Bernales et al. 2007). Autophagic 
turnover is partially blocked by fatty acids in hepatocytes (Rubinsztein 2006; Arrasate et 
al. 2004). Decreased autophagic flux associated with decreased lysosomal activity 
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suggests that lysosomal function is a rate-limiting step halting autophagosome 
maturation. This reduces autophagic degradation and leads to more accumulation of 
damaged mitochondria and ER stress-damaged protein. 
  Another reason, as to why we observe increased P-AMPK protein levels coinciding 
with diminished autophagy levels in simultaneous glucose and hypoxia treatments, may 
be the activity of Akt. Interestingly Akt shows just the reverse action from that of P-
AMPK because it inhibits mTOR inhibition by phosphorylating another domain of TSC 
(Inoki et al. 2003).  
Interestingly, in simultaneous 25 mM D-glucose and hypoxia treatments we 
observed a decline in P-AMPK protein expression (Figure 10), which coincides with 
significant increases in ROS production, caspase 3 and 7 activity and Bax protein 
expression (Figure 3, 4 and 6). The relationships mentioned above and the biphasic P-
AMPK protein expression may be explained by P-AMPK- p27kip interactions. The cell 
cycle regulator, p27kip, is involved in G1 arrest. In human mammary cancer-derived 
cells (MCF-7s), apoptosis occurring in serum depletion is inhibited when p27kip 
Thr198 is phosphorylated by P-AMPK; p27kip break down is inhibited and autophagy 
occurs. When p27kip expression is reduced, autophagy is inhibited and apoptosis 
occurs efficiently. That is, the amount of p27kip determines whether apoptosis or 
autophagy is initiated, and apoptosis is avoided to some extent. It seems that P-AMPK 
can induce autophagy and prolong the period leading to cell death (Liang et al. 2007). 
The findings of this previous study may explain the increased apoptotic cell death 
observed in simultaneous 25 mM D-glucose and hypoxia treatments. Thus our results 
suggest that the decrease in PAMPK, in hypoxia, not only fails to activate protective 
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autophagy but also allows for efficient apoptosis to occur.  
Overall PAMPK protein levels, in normoxia, decreased with increasing D-
glucose levels due the sufficient ATP states. Our treatments of simultaneous glucose 
and hypoxia voids the ATP depletion caused by hypoxia and the 
ischemia/AMPK/mTOR/cardio-protective autophagy pathway is not followed. 
Mitigation of cardio-protective autophagy leads to the accumulation of damaged 
mitochondria and promotes the intrinsic pathway of apoptosis. Despite elevated P-
AMPK protein levels, autophagy is still diminished in simultaneous glucose and 
hypoxia conditions. This may be due to a defective step in the autophagy mechanism or 
the opposing activity of Akt. Diminished autophagy levels and elevated ROS, caspase 3 
and 7 activity and pro-apoptotic Bax protein expression, in simultaneous 25 mM D-
glucose and hypoxia treatments, may be due to declined P-AMPK protein levels not 
only failing to activate protective autophagy but also allowing for efficient apoptosis to 
occur. 
 
1.5 The possible cumulative effects of hypoxia and hyperglycemia on 
cardiovascular function 
 Increased ROS production was shown to be associated with increased apoptosis in 
hearts of diabetic mice (Barouch et al. 2003). It has been proposed that ROS- mediated 
cell death could promote abnormal cardiac remodeling, which may contribute to the 
characteristic morphological and functional abnormalities that are associated with 
diabetic cardiomyopathy (Boudina and Abel 2007). Increased ROS production in diabetic 
hearts can trigger the accumulation of ceramide, which is involved in triggering 
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cardiomyocyte apoptosis, cardiac pump failure, and cardiac arrhythmias (Hayat et al. 
2004). 
 It is evident that apoptosis plays a key role in the pathogenesis of a variety of 
cardiovascular diseases including myocardial infarction, dilated cardiomyopathy and end-
stage heart failure (Olivetti et al. 1996; Saraste et al. 1997; Narula 1996; Aharinejad et al. 
2008) as well as in animal models of ischemia– reperfusion injury (Cheng et al. 1996; 
Gottlieb et al. 1994; Gao et al. 2008).   
 Anti-apoptotic proteins Bcl-2 and Bcl-xl protect cardiomyocytes against various 
stressors. Over-expression of Bcl-xl in H9c2 cardiomyocytes protects against hypoxia-
mediated apoptosis by preserving mitochondrial integrity (Reeve et al. 2007), and Bcl-2 
can prevent p53-mediated apoptosis in cardiomyocytes (Kirshenbaum and de Moissac 
1997). Transgenic mice overexpressing Bcl-2 in the heart have reduced I/R injury and 
show fewer apoptotic cells compared to wild type mice, suggesting that the cardio-
protective effect of Bcl-2 is via inhibition of the mitochondrial death pathway (Imahashi 
et al. 2004; Brocheriou et al. 2000; Chen et al. 2001i).  
 Moreover, in failing hearts with adverse remodeling, increased wall stress 
represents a significant barrier against which cardiomyocytes must contract. These cells 
are expected to require a greater energy supply than those in a healthy heart, which could 
lead to relative hyponutrition, trigger AMPK activation, and induce autophagy. On the 
other hand, it was recently reported that there is latent hypoxia in the failing heart (Sano 
et al. 2007) which could interfere with ATP synthesis and reduce both the contraction and 
relaxation of cardiomyocytes.  Baldi et al. (2002) reported that apoptotic loss of surviving 
cardiomyocytes contribute to the progression of post-infarction cardiac remodeling and 
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dysfunction (Baldi et al. 2002).  
 The inhibition of autophagy has been observed to trigger apoptosis (Boya et al. 
2005). ATG5 knockout, in vitro, in NRVM decreases autophagic activity, induces a 
classic hypertrophic response, increased cell size, caspase 12 cleavage and decreased cell 
viability. Loss of autophagy, in the heart, triggers hypertrophic growth, cardiac 
dysfunction, and ultimately heart failure (Nakai et al. 2007). Lamp-2 protein deficiency 
blocks autophagosomes-lysosomes fusion, the resultant impairment of autophagic 
degradation and excessive accumulation of autophagasomes and long-lived proteins 
progresses into in cardiomyopathy (Maron et al. 2009). Together, these results point to 
the crucial housekeeping role of autophagy in cardiac cells in conditions of high glucose 
and hypoxia.  
 It is quite clear that apoptosis and autophagy, in the cases mentioned, seems to be in 
an antagonistic relationship with each other. Each process consists of opposing goals. 
Kanamori et al. (2011) induced myocardial infarction in mice by ligating the left 
coronary artery to investigate autophagy levels post-infarction. Autophagy was activated 
in surviving cardiomyocytes and chemical inhibition of autophagy significantly 
aggravated post-infarction cardiac dysfunction, remodeling and cardiac hypertrophy. 
Chemically enhancing autophagy reduced cardiac dysfunction and adverse remodeling. 
This suggests that activation of autophagic machinery is a compensatory response aimed 
at increasing the energy supply to meet the cellular demand in the face of excessive wall 
stress and hypoxia, which can cause a low-energy state in cardiomyocytes (Kanamori et 
al. 2011). Buss et al. (2009), further supports these findings by demonstrating that mTOR 
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inhibition increased autophagy and attenuated adverse remodeling following myocardial 
infarction (Buss et al. 2009).  
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Summary/Conclusion 
 
 Accordingly to our results the combined effects of high glucose and hypoxia reduce 
H9c2 cell viability. Simultaneous high glucose and hypoxia-induced oxidative stress 
suppresses cardio-protective autophagy and promotes cell death by apoptosis. The 
biphasic induction of ROS production, caspase 3/7 activity and PAMPK protein 
expression, in simultaneous high glucose and hypoxia conditions, calls for further 
research. Simultaneous high glucose and hypoxia likely voids the ATP depletion caused 
by hypoxia alone and the ischemia/AMPK/mTOR/cardio-protective autophagy pathway 
may not be followed. Further investigation into targets upstream and downstream of 
AMPK and of cellular ATP levels is advised to confirm. Mitigation of cardio-protective 
autophagy, needed to remove damaged mitochondria, may trigger mitochondrial ROS-
induced ROS release and induction of the intrinsic pathway of apoptosis. PAMPK protein 
expression patterns, during high glucose and hypoxia, suggest the impairment of 
protective autophagy and the consequent induction of apoptotic cell death in H9c2 
cardiomyocytes. It may be possible that defective step(s) in the autophagy process inhibit 
autophagy, reduce autophagic flux and the maintenance of ATP production in 
simultaneous high glucose and hypoxia conditions, leading to elevated activation of 
AMPK proteins. 
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